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ABSTRACT
Aflatoxin 81 Metabolism in Mammalian
Pulmonary Tissue

by

J. Michael Eichelberger, Doctor of Philosophy
Utah State University, 1997

Major Professor: Roger A. Coulombe Jr.
Department: Animal , Dairy and Veterinary Science

Aflatoxin 8 1 (AFB 1) is a potent dietary hepatocarcinogen and may be a
lung carcinogen when inhaled. To study the relative ability of lung and liver to
metabolize AFB 1, a susceptible (Swiss-Webster rat) and resistant species (Syrian
golden hamster) were pretreated with inducing agents in order to identify specific
AFB 1 metabolizing enzymes in each tissue.
Analysis of AFB 1-exo-epoxide (AFBO) formation , 0-dealkylation assays,
and protein immunoblots demonstrated that cytochrome P450 (CYP) 1A proteins
were overexpressed in both the lung and liver of hamsters pretreated with 3methylchyolanthrene (3-MC). Only CYP1A1 was expressed in the lung and there
was no indication that this protein was involved in AFB1 activation. CYP1A2, on
the other hand, was induced in the liver and this correlated well with both
increased protein activity and AFBO formation . It would appear that CYP1A2 is
important in activating AFB 1 in hamster liver.
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Although the hamster is resistant as compared to the rat , AFBO formation
was higher in both the lung and liver of the hamster compared to the rat.
Glutathione S-transferase (GST) Yc subunits were detected in the lung and liver
of both species but were not induced by the inducing agents used in these
experiments.
Following intratracheal injections of [3H]AFB 1 , in the rat, specific activity
was localized in the liver. Only a fraction of the activity was detected in the lung .
Of four inducing agents used, only pretreatment with phenobarbital (PB) showed
increased AFB 1-DNA binding in either lung or liver.

This correlated with

increased CYP2B1 protein levels in both lung and liver, as well as increased
CYP2B1 activity and AFBO formation in the liver.
Cooxidation of AFB 1 by purified Prostaglandin H-synthase was shown to
produce AFBO but microsomal fractions from rabbit lung and liver failed to show
detectable levels of AFBO formation by this cooxidative pathway. Neither purified
5-lipoxygenase or cytosolic fractions from rabbit lung or liver showed detectable
levels of LOX mediated cooxidation of AFB, to AFBO.
These studies demonstrate that hamster resembles the human in regard to
AFB 1 activation in the liver, but that a different as yet unknown enzyme is
responsible for hamster lung AFB, activation . Further evidence that the rat is a
poor model for human AFB 1 metabolism was demonstrated with the fact that rat
activates AFB 1 with CYP2B1 , a protein unknown in humans.
(130 pages)

iv
ACKNOWLEDGMENTS

This dissertation is dedicated to my family; my wife, Debbie, my daughter,
Jennifer, and my son , Jonas, for their love, support, understanding , and patience.
I also thank my mother and my brother, Bob, and his wife, Betty, for their constant
love and support throughout my doctoral program .
I am indebted to Dr. Roger Coulombe, Jr., my major professor, for his
advice and guidance throughout my studies here at Utah State University.
would also like to thank my committee members, Dr. Dave Drown, Dr. Brad
Kropp, Dr. Tom Grover, and Dr. Lance Seefeldt, for their time and willingness to
serve on my committee.
I could not have finished my degree if it had not been for the help and
friendship of Mike Huie, who mentored me, and taught me the skills I needed to
work in a toxicology laboratory. Special thanks goes to my friends Pat Klein and
Terry VanVleet, who made the lab fun and a pleasant place to work.
Finally, special thanks goes to Art and Ruth Moss. They are two of the
finest people I have ever known, and their support in all aspects of my time at
Utah State University is immeasurable. I will value their friendship the rest of my
life.
J. Michael Eichelberger

v
CONTENTS
Page
ABSTRACT ............. ... .. ................. ..... ... . ....... .... .. .... ... ..... ....... ... .. .

......... ii

ACKNOWLEDGMENTS .......

.. ...... iv
.. ... vii

LIST OF TABLES ...

LIST OF FIGURES . . .. .... ....... . .. .. ... . . . .. .. ... .. ........ .. .. .. ...... .. .. . .. ........ vi ii
CHAPTER
1.

LITERATURE REVIEW ............. .. .. .... .. .. ... ............ ...... .

.. .. 1

OCCURRENCE OF AFLATOXINS .. . .. .. .. .. . .. .... .. .... .
.. 1
ANIMAL TOXICITY ... . ............................ ....... .. .. ......... .. .... .. ........... 3
EFFECTS OF AFB 1 IN HUMANS .. .... .. .. .. . .. . . .. .. .... ...... ....... ..... .. 4
METABOLISM OF AFB,: ACTIVATION ............... .... ...... ... . ....... 5
METABOLISM OF AFB,: DETOXIFICATION ..
............ .. ...
.. 7
MOLECULAR ACTION OF AFB 1 .......................... . ........ .. ..... .. . .. .. . . . . 9
AFB 1 AND HUMAN LUNG CANCER .. .. .. .. .. ...... ............................. 10
MODULATION OF AFB, METABOLISM ......... ......... .. .................... 12
RESEARCH GOALS........ ........... .. .. .... .. ..... ... ..
............... 13
REFERENCES ... ......... .... .. .. ....... .... .... .. .. .. ..... .. .. ....... .. .......... ... 14

2.

AFLATOXIN B1 METABOLIZING
ENZYMES IN LUNG AND LIVER
OF THE SYRIAN GOLDEN HAMSTER .. ..... ... ... ...................... 28
.. ... 28
ABSTRACT.. .. .................................... ... .. .... .. ... .. .. ... .
INTRODUCTION . ... .. .... .... . .. .. .. .. .. .... .. .... .. .. . .
.. .. ..... ..... 29
MATERIALS AND METHODS....... ... ....... ....... .... ......
....... ...... 32
RESULTS ..
.............. .. ... .. .. .. .... ..........
....... 38
DISCUSSION... . .. .. . .. .. .. . .. . .. . .. . .... .. ... . .. .. .. .. .. ............. ... .. .. ....... . 40
REFERENCES ......................... .. ...... .. ...... ... ... . .. .... ........... .. .45

3.

METABOLISM OF AFLATODXIN B,
IN THE RAT LUNG AND LIVER.

.... .... .. ... ... .......................... 62

ABSTRACT ..... .... ...... ........ .. ... ...... .... ..... ... .. .. ....... .... ... ................... 62
INTRODUCTION .. .. ....
........ .. ................. .. .. ............. .. ..... 64
MATERIALS AND METHODS...
.. .... ........ ..... .. ........... ... .... . 66
RESULTS ................... .. ........... . .. .. .. ...... .... ......... .... .. .. ............... 73

vi

DISCUSSION ..... ....... ........... ....... ............. ...... ........... ................ ... .. 74
REFERENCES .. .. ..... ...... ............ ............. .................. .......... .. .... ... . 80
4. INVESTIGATIONS OF ALTERNATE FORMS
AFB1 METABOLISM .. .. .. .. .. .... .. .. .. ...... .. .

.. .............................. 99

.. ... 99
ABSTRACT. .. ................ .. ........ . ... ............... . ......... .....
INTRODUCTION ......... ... ... .. ...... .. .. .. ................... .. ....................... 100
MATERIALS AND METHODS ............................................. ......... 10 1
RESULTS .. ................... .. .
.. ......................... 105
DISCUSSION ........ ... .. ... ........ ...
................ ...................... .... 105
REFERENCES ............... ... ..... .... ... .............................................. 107
5. SUMMARY .... .................. ......... .. ...... .................. .............. .. .. .. ......... 114
VITA. ...... .. ... .. .... ... ... .. ... ...... .... .. .. .. ... ... .................. ....... ...... ...... ... .......... ...... .. 119

vii
LIST OF TABLES

Page

Table
2-1

3-1

4-1

CYP1A Activation in Hamster Microsomes from Liver
and Lung as Measured by 0-Dealkylation Assays .... ..
Cytochrome P450 (CYP) 281 Activation in Rat Microsomes
from Lung and Liver as Measured by Pentoxyresorufin
0-Dealkylase Activity ..... ... .... .. .. ... ..... . . .. .. .... .. ... ..

.... ... .... .... . 53

... ... ..... 89

Aflatoxin 8 1-exo-8,9-epoxide (AFBO) Formation by Cooxidative
Enzymes as Measured by AFB 1-GSH Formation and
Detected by HPLC ......... .... .. .......... .. .. ... ..... ..... ... .. .. ... .......... ......... .... ..... . 111

viii
LIST OF FIGURES

Figure

Page

1.1

Structure of aflatoxins ..

1.2

Overview of AF8 1 biotransformation pathways .

. ...... ...... ...... ... .. 25

1.3

Cytochrome P-450 oxidation products of AF81

......... ..... .......... 26

1.4

Primary products of AF81-exo-epoxide ........................................... ....... 27

2-1

Double reciprocal plot of aflatoxin 81-exo-epoxide (AF80)
formation as measured by aflatoxin 81-glutathione (AF81-GSH)
conjugate formation in hamster lung microsomes ........ ........ ......... .. .... ... 54

2-2

Double reciprocal and Eadie-Hofstee plots of aflatoxin 81 -exoepoxide (AF80) formation as measured by aflatoxin 8 1-glutathione
(AF8 1-GSH) conjugate formation in hamster liver microsomes ....... ........ 55

2-3

Aflatoxin 81 (AF81) activation measured as AF81-glutathione
(AFB 1-GSH) formation in hamster lung and liver

2-4

.... .... .. 24

Inhibition of aflatoxin 8 1-exo-epoxide (AF80 ) formation by
hamster liver microsomes by CYP1A inhibitors

....... 56

... .. 57
..... .. 58

2-5

Cytochrome P450 (CYP) 1A expression in hamster .....

2-6

Effect of 3-methylcholantene (3-MC) pretreatment on expression
of glutathione S-transferase (GST) Yc in hamster lung and liver ... ..... .... 59

2-7

Glutathione S-transferase (GST) activity as measured by the
chlorodinitro benzene (CDN8) assay .... ......... ..
. ... ... ....... ... ... ... .... 60

2-8

Protein dependency of glutathione S-transferase (GST) mediated
trapping of aflatoxin 8 1-exo-epoxide (AF80) .. .... ... .... .. ... .... . ... .. .. .

.... 61

3

3-1

[ H] Aflatoxin 8 1-DNA binding in rat lung following intratracheal
3
injection of 15 J.!Ci [ H] AF81 (0.1 mg/kg) ............ .... .. ... ......... .. ... ..... ........ 90

3-2

[ H] Aflatoxin 6 1-DNA binding in rat liver following intratracheal
3
injection of 15 J.!Ci [ H] AF8 1 (0.1 mg/kg) ... ....... ..... ..... .... . ...... ...

3

. ....... 91

ix
3-3

3-4

Aflatoxin B1 (AFB 1 ) activation measured as AFB 1-glutathione
(AFB 1-GSH) conjugate formation in rat lung and liver .. .

. .. ... 92

Effect of phenobarbital (PB) pretreatment on immunoreactive
microsomal cytochrome P450 (CYP) 2B1 in rat lung (A)
and liver (B).
........ ....... ..
...... .........

.. ........ .. . 93

3-5

Effect of 3-methylcholanthrene (3-MC) pretreatment on immunoreactive microsomal cytochrome P450 (CYP) 1A in rat lung (A)
and liver (B) .... ... ............
.. .. .. ..... ..... .. .. .. ..... 94

3-6

Effect of pregnenalone-16-a-carbonitrile (PCN) pretreatment on
immunoreactive microsomal cytochrome P450 (CYP) 3A in
rat lung (A) and liver (B) ...
. ... ... ... .. .. .. .. .. ..

.. .. .. ... 95

3-7

Effect of monosodium glutamate (MSG) pretreatment on immunoreactive microsomal cytochrome P450 (CYP) 2C11 in rat lung (A)
and liver (B) . ... .. .. .. .. .. ... .. .
.. .. .. .. .. .. .. .. .. ..
.. ................ ...... .. 96

3-8

Effect of phenobarbital (PB) and 3-methylcholanthrene (3-MC)
pretreatment on immunoreactive cytosolic glutathione S-transferase
(GST) Yc in rat lung (A) and liver (B) ............ . .......... ............
.. .......... 97

3-9

Glutathione S-transferase activity as measured by the chlorodinitro
benzene (CDNB) assay ...............
.. .. .. .. .. .. .. .. .. .. .. .. .. .
.. ...... 98

4-1

Comparison of prostaglandin H-synthase (PHS) activity in rabbit
lung and liver .......................... ................... .. .. .... .. .... .. .. ......

4-2

.. .... 112

Comparison of lipoxygenase (LOX) activity in rabbit lung and liver ....... 113

CHAPTER 1
LITERATURE REVIEW

OCCURRENCE OF AFLATOXINS

Aflatoxins are a group of secondary metabolites produced by the molds
Aspergillus flavus and Aspergillus parasiticus.

These products are produced

when the fungi are under physiological stress and occur in both animal feeds and
agricultural commodities destined for human consumption (Jelinek eta/. , 1989).
Aflatoxins have been found in many products, including cotton seed,
peanuts, peas, pecans, cheese, bread , and grains such as wheat, rice, barley,
corn, and sorghum (Cole eta/., 1989; Denning , 1987; llag, 1975; Newberne and
Butler, 1969; Payne, 1992; Stoloff 1983; Wilson and Abramson, 1992). A. flavus
is also pathogenic on several fruits such as citrus, guavas, papayas, pineapples,
and pomegranates (Snowdon, 1992; Wilson and Ogawa, 1979). In the United
States, products made from peanuts and corn are the most significant sources of
aflatoxin in the human diet (Burget a/., 1981).
Aflatoxins were first discovered in 1960 following an outbreak of a disease
that resulted in the deaths of thousands of turkeys, ducks, and pheasants in
England (Busby and Wogan, 1984). The disease was named Turkey X disease
and was characterized by parenchymal cell degeneration, bile duct proliferation,
and massive hepatic necrosis (Roebuck and Maxuitenko, 1994).
The genus Aspergillus occurs worldwide {Alexopoulos, 1962; Raper, 1965),
but the occurrence of aflatoxin is limited to warmer areas of the world and its
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distribution is concentrated in tropical and warmer temperate regions , with subSaharan Africa and southeastern Asia being most important. It is also found in
the United States, especially in the Southeast and portions of the Midwest.
The name aflatoxin (AF) is derived from the contraction of the genus name
Aspergillus and the species epithet flavus. There are four aflatoxins, which are
shown in FIG. 1-1 , and are designated as AFB1 , AFB2 , AFG1, and AFG 2 . All are
found in various proportions in agricultural products. However, AFB 1 is the most
predominant and also the most toxic. The 'B" and "G" designation refers to the
blue and green fluorescence, respectively, that each of these molecules emits
when irradiated with ultraviolet light.

Each congener is designated ' 1" or ' 2" and

refers to the vertical orientation of each molecule when separated on a thin layer
chromatography plate.

AFB 1 and AFG1 are unsaturated at the 8,9 and 9,10

carbon bonds, respectively, in the terminal furan ring , and this accounts for their
high biological activity.
In certain parts of the world, AFB1 has been associated with several
diseases, including hepatotoxicity, Kwashiorkor, and Reye's syndrome (Cullen
and Newberne, 1994; Hendrickse, 1991; Ngindu eta/., 1982; Shank, 1981 ; Van
Rensburg, 1977; Wild et a/., 1992). The relationship of aflatoxin to kwashiorkor
and Reye's syndrome is tentative, but the association with hepatotoxicity
(aflatoxicosis) is well documented .

In India during the fall of 1974, 387 people

became ill and 108 died from ingestion of aflatoxin-contaminated corn (Tandon et
a/., 1978).

A second outbreak of aflatoxicosis occurred in Kenya in 1982. There

were 20 hospital admissions with a 60% mortality; daily aflatoxin intake was
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estimated to be at least 38 f..lg/Kg body weight for an undetermined number of
days (Groopman eta/., 1992a).
Although there have been outbreaks of aflatoxin poisoning in animals and
people, the main concern with AFB 1 in human health is the risk it poses as a
cancer-causing agent. This is of particular concern in developing countries where
long-term food storage is inadequate, especially in regards to high heat and
humidity, which favor rapid growth and spread of the fungus (Eaton and
Gallagher, 1994).

ANIMAL TOXICITY

AFB1 is one of the most potent animal carcinogens known.

A 100%

incidence of hepatic tumors in rats occurs, when fed a diet containing 1OOppb
AFB1 for 54-88 weeks (Wogan eta/. , 1974). In rats, AFB1 is 1000 times more
carcinogenic than benzo(a)pyrene, and of all other agents tested, only 2,3, 7,8tetrachlorodibenzo(a)dioxin (TCDD) is significantly more potent (Gold et a/.,
1984).
Several species have been shown to be susceptible to AFB1 exposure
(Newberne and Butler, 1969; Wogan, 1973), and there is considerable variability
in sensitivity between species. Both rainbow trout and the rat are particularly
susceptible, whereas mice and hamsters are resistant (Eaton and Ramsdell,
1992).
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EFFECTS OF AFB1 IN HUMANS

Several epidemiological investigations implicate AFB 1 as a human
carcinogen (Bruce, 1990; Groopman

et a/., 1992b; Groopman et a/., 1993).

Aflatoxin seems to play a causative role in the unusually high incidence of
hepatocellular carcinoma in some parts of the world. This type of cancer has one
of the poorest 5-year survival rates of any known neoplastic disease (Groopman

et a/., 1992a). Hepatocellular carcinoma (HCC) is a relatively uncommon tumor
in the United States, accounting for less then 1% of all reported cancer cases.
However, in regions such as Africa, southeast Asia, and China, HCC is a major
health problem causing up to 50% of all cancer cases (Leon and Kew, 1996).
Aflatoxin B, is a major risk factor in the etiology of human hepatocellular
carcinoma. Increased incidences of HCC in Africa and Asia coincide with high
levels of dietary AFB, intake. In an effort to establish a link between AFB 1 and
dietary exposure, several biomarkers have been used to detect exposed
members of the population (Groopman and Kensler, 1987; Groopman
1992b; Guengerich

et a/.,

et a/., 1992). Hepatitis B virus, which is also considered a

causative agent of primary liver cancer, has confounded efforts to positively
identify AFB, as the cause of human liver cancer (Stoloff, 1989).

However, the

International Agency for Research on Cancer (IARC, 1993) has decided that
there is sufficient evidence to classify AFB, as a Group 1 (confirmed) human
carcinogen.
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Recent evidence suggests that

AFB1 and hepatitis B virus interact

synergistically to enhance the risk of an individual developing HCC. Ross et a/.,
(1992) examined an African population for the presence of urinary AFB 1-N 7 guanine adducts and positive reactions to hepatitis B antigen and found that
AFB1 exposure alone (hepatitis B antigen-negative) yielded a risk factor of 2;
hepatitis B virus antigen alone (aflatoxin exposure negative) yielded a relative risk
of 5. However, combined exposure to both agents yielded a relative risk of over
60.

A possible explanation for the synergism is that viral infection and
associated liver injury alter expression of carcinogen-metabolizing enzymes. In
transgenic mice, the

expression of specific cytochrome P450s is altered in

association with overexpression of HBV large envelope protein and liver injury
(Kirby eta/., 1994). In this transgenic mouse lineage, overproduction of the HBV
large envelope protein results in progressive liver cell injury, inflammation , and
regenerative hyperplasia.

METABOLISM OF AFB1: ACTIVATION

AFB1, like most chemical carcinogens, requires metabolic activation in
order to exert its toxic effects. Aflatoxin metabolism is complex and the various
fates of its biotransformation are outlined in FIG. 1-2.

Differences in these

biotransformation pathways are a critical factor in determining variations in
species sensitivities to AFB1-induced carcinogenesis.
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Metabolism is largely mediated by GYP mixed function oxidases, which are
located in smooth endoplasmic reticulum of the liver cells and in other tissues
throughout the body. These enzymes catalyze the epoxidation , hydroxylation , and
0-demethylation of AFB1 (FIG . 1-3). Genetic variability in the expression of
aflatoxin

biotransformation

pathways results

in

substantial

differences in

susceptibility to the carcinogenic effects of aflatoxins.
Though of lesser importance, AFB 1 activation can also occur through
cooxidation during the biotransformation of arachidonic acid (20:4ro6) by
lipoxygenase and prostaglandin H synthase (PHS) (Liu et at. ,1992). Activation of
AFB1

by PHS was first demonstrated in ram seminal vesicles (Battista and

Marnett, 1985) and later in guinea-pig kidney and liver (Liu et at., 1990).
Using mouse fibroblasts, Amstad and Cerutti (1983) reported that
indomethacin , a specific inhibitor of PHS, significantly reduces binding of AFB 1 to
3

cellular DNA, and also found that P-450 inhibitors had no effect on [ H] AFB 1
adduct formation, suggesting that this reaction was independent of P-450
catalyzed AFB 1-DNA binding .
The aflatoxin exo-epoxide is generated through a free radical mechanism
as a consequence of arachidonic acids metabolism (Eiing et a/., 1990 Reed,
1988). With the exception of red blood cells, all mammalian cells posses PHS
and or lipoxygenase activity (Voet and Voet, 1990).
Unpublished work in Dr. Roger A. Coulombe's lab has shown that PHS
contributes as much as 30% of the AFB 1 activation in cultured rabbit airways.
Additional work is needed to quantify the actual levels of PHS in pulmonary
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systems and compare to those in hepatic tissue.

This further research will

provide additional information on the sensitivity of airways to the genotoxicity of
AFB,.
Metabolic activation of AFB 1 produces the electrophilic reactive AFB 1-8,9epoxide intermediate, which is capable of alkylating nucleic acids (Baertschi et
a/., 1989; Essigmann eta/., 1977).

The AFB, exo-epoxide is believed to initiate

carcinogenesis by covalently modifying DNA (Lutz, 1980; Raney eta/. , 1993).
Structurally altered DNA is thought to disrupt the normal recognition elements
between replication enzymes and DNA, leading to misincorporation of nucleotides
in the DNA replication process, causing mutations (Darnell et a/., 1990; Singer
and Berg, 1991).

METABOLISM OF AFB1: DETOXIFICATION

Detoxified polar products of Cytochrome P-450-mediated metabolism
includes aflatoxin M1 (AFM,), aflatoxin P1 (AFP,), aflatoxin Q 1 (AFQ,), aflatoxicoiH1, aflatoxicol (AFL), and aflatoxicoi-M 1 (AFL-M 1). All of these metabolites, with
the exception of AFL, have reduced mutagenic and carcinogenic potential and
are considered detoxified products (Coulombe et a/., 1983; Wong and Hsieh ,
1976).
Detoxification of the AFB,-8,9-epoxide in mammalian airways is mediated
primarily by two enzymes, epoxide hydrolase (EH) and glutathione S-transferase
(GST), with the latter playing the bigger role (Ball and Coulombe,1991).

Neal
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(1990) found that hepatic GST-mediated detoxification of AFB 1-8,9-epoxide in
C57 mice is twelve times more efficient than that in Fischer344 rats and this is
thought to be the reason for the inherent resistance of AFB 1 in mice.
The GSTs are a superfamily of enzymes consisting of five classes
designated a,

)l,

rr,

e,

and microsomal (Board eta/. , 1990; Hayes et at., 1990;

Hiratsuka et a/., 1990; Meyer et a/., 1991). Differences exist in the AFB1-8,9epoxide detoxification capabilities of these different classes. In rat liver, a is by
far the most active (Coles eta/., 1985). GSTs also occur in the lung albeit at
lower levels than in the liver and they are primarily associated with clara cells
(Stewart eta/., 1996; Mainwaring eta/., 1996).
The presence of specific constitutive isozymes of GST contributes to
species resistance to AFB 1.

For example, the mouse, a resistant species,

exhibits high constitutive levels of GST activity towards the AFB1-8,8-epoxide
(Degen and Neumann, 1981 ; O'Brien eta/., 1983).

Detoxification of AFB-8,9-

epoxide by a specific a-class GST is an important protective mechanism in mice
and it accounts for the resistance of this species to the carcinogenic effects of
AFB 1. This particular form of GST is expressed constitutively only at low levels in
rats, but is inducible by antioxidants such as ethoxyquin (EQ). This GST form
accounts for much of the chemoprotective effects of a variety of substances,
including natural dietary components that putatively act via an antioxidant
response element (ARE).
The toxicity of AFB1 can be attenuated by the administration of agents
that induce GSTs. Hayes eta/. {1991a) have shown that ethoxyquin treatment in
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rats results in a marked increase in the expression of the a-class GST Yc2 which
has

high

activity towards AFB1-8,9-epoxide.

AFB1-induced

tumors or

preneoplastic lesions in experimental animals can be inhibited by co-treatment
with several compounds, including indole-3-carbinol (13C), a component of
cruciferous vegetables and an Ah receptor agonist 13-naphthoflavone (Stresser et
a/., 1994). Likewise, the administration of the antioxidants EQ, butylatedhydroxyaniline

(BHA),

or

butylatedhydroxy

toluene

(BHT) ,

as

well

as

phenobarbital (PB), can produce marked increases in levels of the GST Yc2
subunit in rat liver, with specific detoxifying activity towards the AFB1-8,9-epoxide
(McClellan eta/., 1994).

MOLECULAR ACTION OF AFB1

There is strong evidence that AFB1-8,8-exo-epoxide binds to G:C rich
regions of DNA, forming an adduct at the N7 -position of guanine. Substantial
evidence demonstrates

that AFB1-8,8-exo-epoxide can

induce activating

mutations in the ras oncogene in experimental animals, primarily at codon 12.
Mutations that occur in tumor suppresser genes such as P53 or oncogenes
(McMahon eta/. , 1986) can result in the development of cancer. Point mutations
in Ha-ras, Ki-ras, and N-ras oncogenes at either codons 12, 13, or 61 have been
found to be activating events in rodents and represent an important step in the
development of animal tumors (Balmain and Brown, 1988; Buchmann et a/.,
1991).
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Mutations in Ha-ras predominate in mouse liver tumors, but mutations in
Ki-ras and N-ras genes are associated with AFB1-initiated tumors in the rat.
Although activation of Ki-ras (Sinah eta/., 1988) is predominately characterized
by a G:C-to-A:T transition at the second nucleotide in codon 12, a G:C-to-T:A
base transversion at position 2 in codons 12 and 13 has also been found (Chang
et a/., 1991 ; McMahon et a/., 1986; McMahon et a/., 1990).

AFB1 -induced

prenoplastic nodules in the mouse were found to frequently contain either a C to
A transversion in the first nucleotide or an A to T transversion in the second
nucleotide of codon 61 (Bauer-Hoffman eta/. , 1990).
In humans, mutations are found in the P53 gene rather than ras genes
with about a 50 percent occurrence of mutations reported in hepatocellular
tumors (Hollstein et a/., 1993). In vitro assays of the human P53 gene have
shown codon 249 to be a preferential mutation site (Puisieux et a/. , 1991).
Chronic long-term exposures such as those that might occur as a result of
inhalation by workers exposed to AFB1 contaminated grain dusts, may result in
P53 mutations.

AFB1 AND HUMAN LUNG CANCER

Although AFB1 primarily targets the liver (Hsieh et a/., 1977; Wogan,
1977), both pulmonary (Dickens eta/., 1966) and renal (Busby and Wogan , 1984)
cancers have also been found following AFB1 treatment in experimental animals.
While most human exposure to AFB1 is a result of ingestion of contaminated
foods , considerable occupational exposure also occurs from inhalation of infested
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AFB 1-contaminated

dusts

during

harvesting,

storage,

processing,

and

transportation of grains such as corn, peanuts, and rice (Shotwell and Burg ,
1982; Sorenson eta/. , 1984).
Surveys have shown that AFB 1 is often found in higher concentrations in
respirable dusts than in contaminated foods. Daily exposure rates of 40 to 856
ng of AFB, have been calculated from a corn processing plant, where the
average respiration rate was estimated at 1m3/hr (Burg eta/., 1981) and the
measured concentration in the air was 107ng/m 3 .
Epidemiological studies support the supposition that AFB 1 inhalation
increases the incidence of tumors in exposed individuals. Hayes eta/. (1984)
found increased respiratory tumor incidence in workers at a peanut processing
plant who were exposed to AFB 1-contaminated peanut dust relative to unexposed
cohorts. In this study, no hepatocellular tumors were found, whereas tumors of
the airways and lung were predominant. Dvorockova (1976) reported the case
histories of two chemical engineers who developed pulmonary adenomas from
sterilizing AFB 1-contaminated peanut meal.
Further evidence of the potential risk to human airways from AFB 1
inhalation has been seen with animal studies. AFB 1 incubated with microsomal
preparations from bovine olfactory mucosa has been shown to bind to DNA more
readily then similarly treated liver preparations (Tjalve et a/., 1992).

Kinetic

studies of the Vmax and km of AFB, DNA-binding in rabbit lung and liver (Daniels

eta/., 1990) have shown that these kinetic paramaters are equal in both tissues,
which implies that AFB, bioactivation is at least as efficient as that in the liver.
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Aflatoxin B1-DNA adduct analysis studies of animals dosed intratracheally
with microcrystaline AFB 1 in saline solution to simulate respiratory exposure
(Coulombe

et

a/.,

1991)

showed

no

significant

differences

in

the

pharmacokinetics between AFB, bound to either ferric oxide, grain dust, or AFB 1
in saline solution . Zarba eta/. (1992) compared aflatoxin-DNA adduct formation
in rat liver following either nose aerosol or intratracheal injection of AFB, . They
found a linear dose-response relationship which correlated with increasing length
of exposure to the amount of AFB,-N 7-guanine adducts formed per mg DNA.
The intratracheal injection proved to be a reliable model for nose only inhalation.
Species susceptibility to AFB 1 is determined by the relative contribution of
activating and detoxifying schemes operating in the animal (Lotikar, 1989; Neal,
1990).

Hayes el a/. (1991b) identified three types of resistance:

intrinsic,

inducible, and acquired. Resistance to AFB, is a result of low high detoxification
rates, high AFB 1 efflux from cells, and high DNA repair capability.
MODULATION OF AFB1 METABOLISM

Hepatic metabolism of AFB, is affected by exogenous chemicals. The
activation of AFB 1 to the genotoxic epoxide is enhanced through induction of
cytochrome P-450 in liver microsomes following pretreatment with polychlorinated
biphenyls (Ishii el a/., 1986). Metcalfe el a/., (1981) have demonstrated that the
ability of rat liver to activate AFB, is increased by pretreatment of rats with
phenobarbital.
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Induction patterns are often different in different species. For example,
when administered in the rat, 3-methylcholanthrene (3-MC) stimulates a tenfold
increase in the AFM1 detoxification product (Metcalfe et a/., 1981), but in the
hamster, 3-MC induces two different P-450s, both of which are efficient AFB1
epoxide formers (Fukuhara eta/., 1990).

Nothing is known about how these

agents effect pulmonary metabolism of AFB1 .

RESEARCH GOALS

Aflatoxin B1 is a pulmonary carcinogen in experimental animals, and
epidemiological studies have shown an association between AFB1 exposure and
lung cancer in humans (Donnelly et a/., 1996). Several studies from Dr.
Coulombe's lab have described the bioactivation of AFB 1 in the upper airways
(Ball and Coulombe, 1991; Ball eta/., 1990; Ballet a/., 1995; Coulombe eta/.,
1986; Wilson eta/, 1990). In at least two species, nasal respiratory and olfactory
mucosa have been shown to have a higher capacity to form DNA-bound AFB1 metabolites than the liver (Larsson and Tjalve, 1995; Larsson and Tjalve, 1996).
Inhalation of AFB 1 in occupational settings occurs concurrently with
exposure to other chemicals, some of which may influence the ultimate fate of
AFB1 in the body.

Although there is a growing amount of evidence that

exogenous inducing agents influence AFB1 metabolism in the liver, no information
exists concerning modulation of AFB1

metabolism in the lung.

These

experiments test the hypothesis that exposure to certain exogenous agents
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induces phase I and phase II, enzymes, which in turn modulate the genotoxic
effects of AFB 1.
The experiments outlined herein examine factors that modulate the
expression of P-450 and GST responsible for metabolic processes that lead to
AFB1-induced carcinogenesis or detoxification . Metabolic activation of AFB1 to
the genotoxic AFB 1-8,9-epoxide was determined by measuring total [3H]-AFB 1DNA binding in the lung and compared to binding in the liver.
Experimental results from hamster showed that 3-methylcholanthrene
induced CYP1A2 in hamster liver and increased AFB 1 activation in this organ .
CYP1A protein was also induced in the lung but increased activation was not
noted and it is likely that CYP1A1 was the protein that was overexpressed. In the
rat, phenobarbital induced CYP2B 1 in both the liver and the lung and stimulated
increased AFB 1 activation in both tissues. Rat was judged a poor model for AFB 1
human exposure since different proteins are responsible for AFB 1 activation in
humans.

High pressure liquid chromatography separation coupled with ultra-

violet (uv) detection proved to be a poor system for determining AFB, cooxidation
to AFB, -exo-epoxide.
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FIG. 1-1 . Structure of aflatoxins.
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CHAPTER2
AFLATOXIN 81 METABOLIZING ENZYMES IN LUNG AND LIVER
OF THE SYRIAN GOLDEN HAMSTER

ABSTRACT

Aflatoxin 8 1 (AFB1) is a potent dietary hepatocarcinogen and may be a
lung carcinogen when inhaled . To study the relative ability of lung and liver to
metabolize AFB 1, activation and detoxification of AFB1 in lung and liver of Syrian
golden hamsters were determined as was the effect of 3-methylcholanthrene (3MC) induction. Aflatoxin 81-exo-8,8-epoxide (AFBO) formation in both the lung
and liver did not follow Michaelis-Menten kinetics, which suggests that more than
one GYP isoform is active in AFB1 metabolism.

Pretreatment with 3-MC

increases activation, as measured by the formation of the AFB1 -exo-8,9-epoxideGSH (AFB1-GSH) adduct, showed that lung microsomes from hamsters treated
with 3-MC did not differ significantly from control , whereas 3-MC-induced liver
microsomes produced 5.3-fold more AFBO.

The content of CYP1A was

increased in the lung from nondetectable levels and by 5.4-fold in the liver as
assessed by Western immunoblots. Pretreatment with 3-MC induced CYP1A1
activity 40-fold in the lung and 3.6-fold in the liver while CYP1A2 activity was
raised 10-fold in the lung and 5.6-fold in the liver. Aflatoxin 81-exo-8,9-epoxideGSH formation by microsomes from control and 3-MC-treated animals was
inhibited 48.4% and 57.8%, respectively, by ellipticine (a specific CYPIA inhibitor) ,
and 33.3% and 45.4%, respectively, by furaffyline (a specific CYPIA2 inhibitor).
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This study suggests that the lung (as well as the liver) is capable of producing
AFBO, albeit at lower levels, and that CYPIA2 protein is involved in activation in
the liver but probably not in the lung.

Although 3-MC induces overall GST

activity, the Yc isoform expression is unaffected in both lung and liver. At low
protein levels, hamster GST is similar in AFBO trapping activity to the rat, but at
higher levels it approaches BHA-induced mouse cytosol in AFBO detoxification.
Therefore, the hamster efficiently detoxifies AFBO, and this may underlie the
resistance of this species to AFB1 .

INTRODUCTION

Aflatoxin B1 (AFB1) is a mycotoxin produced as a secondary metabolite by
the molds Aspergillus flavus and parasiticus.

It is a worldwide contaminant of

food and feed (Jelinek eta/. , 1989) and is a potent animal carcinogen (Busby and
Wogan, 1979; Roebuck and Maxuitenko, 1994). Species and tissue susceptibility
to AFB1-induced carcinogenesis varies (Cole eta/., 1988; Lutz et al. , 1980). Rats
are susceptible, whereas mice and hamsters are relatively resistant (Enomoto
and Saito, 1972; Moore eta/., 1982; Newberne and Butler 1969).
Although the liver is the principal target organ of AFB 1, effects have also
been found in other tissues (Bailey et a/. , 1988; Croy and Wogan , 1981).
Aflatoxin is also activated in lung tissues from various species, including human
(Ball eta/., 1990; Ball eta/. , 1995; Wilson eta/. , 1990).

This is a cause of

concern with regard to potential human respiratory exposure to AFB1-
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contaminated dusts generated in the harvest and processing of grain and nut
products.
Epidemiological evidence suggests that AFB 1 may be an etiological agent
for human liver cancer in several parts of the world (Allen et a/., 1992; Bosch and
Munoz, 1989; Groopman , 1994; Groopman eta/. , 1993; Hall and Wild, 1994).
Aflatoxin 81 is toxic and carcinogenic in extrahepatic tissues (Akao et a/, 1971;
Herrold , 1969; Wieder et a/. , 1968; Yoneyama et a/., 1987).

Surveys of

agricultural processing facilities have found that dusts generated from corn,
peanut, and

cottonseed

processing

plants,

can

have

levels

of AFB 1

contamination exceeding that found in contaminated food products and feeds
(Burget a/., 1981; Hayes eta/., 1984; Sorenson eta/. , 1984).
The risk AFB1 poses through inhalation is not as firm as that from
exposure through diet. Data from epidemiological studies have conflicted as to
the role of AFB 1 in inducing pulmonary cancers. Case studies describe situations
in which workers who were exposed to AFB 1-contaminated grain dusts during the
course of their work developed tumors (Deger, 1976; Dvorockova, 1976). Two
epidemiological studies indicate increased incidence compared to unexposed
cohorts of tracheal, bronchial , and liver tumors in a Dutch peanut oil processing
plant where workers were exposed to AFB1-contaminated dusts (Hayes et a/.,
1984; Van Nieuwenhuize eta/., 1973). Another study of workers at a livestock

feed processing plant who were exposed to 170 ng airborne AFB 1 per day
showed no increased occurrence of respiratory cancer as compared to the
general population (Olsen eta/., 1988).
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Aflatoxin B1 requires activation to the reactive AFB1-8,8-epoxide (AFBO) to
exert its carcinogenic affects (Eaton et a/., 1994; Essigmann et at.,
Swenson et a/., 1977).

1982;

Differences in metabolic activity between species or

tissues determine susceptibility to AFB1-induced carcinogenesis (Busby and
Wogan , 1984; Hsieh eta/., 1977; Patterson , 1973; Salhab and Edwards, 1977).
Cytochrome P450s (CYPs) are the most important enzymes involved in AFB 1
metabolism and are involved both in its activation and detoxification (Eaton eta/.,
1994). The compositions of P450s vary between species and between tissues,
and many are inducible by exogenous agents, which in turn will modify the
metabolism of AFB1 (Metcalfe eta/. , 1981; Pelkonen et at., 1994; Takahashi et
at., 1995).

The extent of covalent binding of AFBO to DNA is highly correlated to the
carcinogenic potency of AFB1 (Busby and Wogan, 1984; Essigman eta/., 1982;
Garner, 1973). The critical initial lesion , the 8,9-dihydro-8-(N 7-guanyl)-9-hydroxyAFB1 , is formed in the reaction of DNA with AFBO (lyer et at., 1994; Lin eta/.,
1977).
Detoxification of the AFBO occurs primarily by glutathione S-transferase
(GST).

The ability of species to trap AFBO by GST is proportional to

susceptibility to AFB1-induced carcinogenesis (Eaton and Gallagher, 1994;
Monroe and Eaton , 1987).
Little is known about AFB1 metabolism in pulmonary tissue. Intratracheal
administration of AFB1 failed to produce a significant incidence of tumors in
hamsters (Coulombe, unpublished).

3-methylcholanthrene (3-MC) induction
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results in greater AFB 1 activation in hamsters than in other species such as rat,
rabbit, and mouse (Fukuhara eta/., (1990). The aims of the experiments in this
chapter were to investigate AFB1 activation and detoxification in the lung and liver
of hamster and to identify the P450 isoform (s) responsible for AFB1 activation.
To do this we examined the effect of 3-MC pretreatment on these parameters.

METHODS AND MATERIALS

Animals

Male Syrian golden hamsters (135-150 g), Swiss-Webster mice (49 days
old) , and Sprague-Dawley rats (200-225 g) were purchased from Simonsen
Laboratories (Gilroy, CA). The animals were maintained on laboratory chow and
water ad libitum.

Chemicals and Reagents

Aflatoxin B1 (AFB1) was purchased from from Calbiochem (San Diego, CA)
and [3 H]AFB 1 was obtained from Moravek Biochem ., Inc. (Brea, CA). Aflatoxin
G1

(AFG1), 3-methylcholanthrene (3-MC) , butylated hyxroxyanisole (BHA),

butylated hydroxytoluene (BHT), 1-chloro-2,4-di-nitrobenzene (CDNB), EDTA.
phenylmethylsulfonyl

floride

(PMSF),

ellipticine,

pentoxyresorufin , ethoxy-

resorfuin, reduced nicotinamide adenine dinucleotide phosphate (NADPH,H+),
and reduced glutathione (GSH) were purchased from Sigma Chemical (St Louis,
MO) .

Methoxyresorufin was obtained from Molecular Probes (Eugene, OR),

resorufin from Aldrich (Milwaukee, WI), furafylline from Gentes! (Woburn, MA),
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and halothane from Halocarbon Laboratories (River Edge, NJ). Authentic exoAFB1-8,9,-GSH (AFB1-GSH) was a gift from Dr. T. M. Harris, Vanderbilt
University

(Nashville,

TN).

Dithiothreitol

(OTT),

electrophoresis

grade

acrylamide, HPLC grade methanol , ammonium persulfate, and tetrahydrofuran
were obtained from Fischer Scientific (Santa Clara, CA) .

Glutathione S-

transferase Yc rabbit antisera was purchased from Biotrin (Dublin, Ireland} and
anti-rat CYP1A1 goat antisera was obtained from Daiichi Pure Chemicals (Tokyo,
Japan) . Goat anti-rabbit lgG and rabbit anti-goat lgG secondary antibodies, both
conjugated to horseradish peroxidase (HRP), were purchased from Bio-Rad
(Hercules, CA).

Chemiluminescent detection of proteins was by (ECL Kit,

Amersham, Arlington Heights, IL).

Nitrocellulose membranes were purchased

from Micron Separations Inc. (Westborough , MA) .

Animal Treatments and Tissue Preparation

3-methylcholanthrene was administered intraperitoneal (i.p.) (25 mg/kg)
in 100 ).!1 corn oil for each of 4 days. Six hours following the last dose, hamsters
were anesthetized with halothane and exsanguated by severing

the brachial

arteries. Preparation of microsomes and cytosolic fractions was a modification of
the method of Matsubara et at., (1974) .

Lungs and livers were removed,

perfused with isotonic saline (0.9% NaCI), and frozen in liquid N2 . All tissues
were stored at -80°C until use.

Livers and lungs were homogenized with a

Polytron (Brinkman Inc., Westbury, NY) with a 7-mm generator in ice cold 0.05 M
KHP0 4 homogenizing buffer (pH 7.4) containing 1 mM EDTA, 0.25 M sucrose,
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0.15 M KCI , 200

~M

butylated hydroxytoluene (BHT), and 200

~M

PMSF. The

homogenate was centrifuged at 600x g for 10 min followed by 10,000 x g for 10
min , and the supernatant was then centrifuged at 105,00 x g for 60 minutes. The
cytosolic fraction was collected and stored at -80°C. The microsomal pellet was
re-homogenized in wash buffer (pH 7.4), which contained 0.1 M Na4P201, 1 mM
EDTA, 20

~M

BHT, and 200

~M

PMSF, then centifuged again for 60 min at

105,000 x g. The microsomal pellet was then re-homogenized in 0.05 M KHP04
(pH 7.4) storage buffer containing 1 mM EDTA, 0.25 M sucrose, 2mM OTT, 200
~M

PMSF, and 20% glycerol,

then stored at -80

oc

Protein

until use.

concentrations were determined according to the Bradford (1976) method utilizing
a plate reader and Kinetic Calc® software suite (BT2000, Fischer Scientific,
Santa Clara, CA).

Microsomal AFB 1 Activation

Microsomal

biotransformation

of AFB1 was

determined

by

HPLC

quantification of the AFBO, as assessed by the formation of the AFB1-GSH
conjugate. Determination of AFB 1 oxidation was carried out in

250-~1

reactions

containing microsomal protein, 2 mM NADPH, H•, and 5 mM GSH , and 80 mM
KHP0 4 buffer (pH 7.6), which included 25 mM sucrose, 25 mM KCI, and 5 mM
MgCI 2 .

BHA-induced mouse cytosol in excess (800

included to provide the glutathione S-transferase.
AFB 1 in 5

~I

~g

cytosolic protein) was

Varying concentrations of

(verified spectrophotometrically; f.v = 360 nm;

&

= 21 ,800) were

added to initiate the reaction. Reactions proceeded for 10 min at 37°C, then the
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reaction was stopped by the addition of an equal volume of ice cold CH30H
containing 15-20 1-1M AFG, (A. = 362 nm;

E

= 17,700) , which was included as an

internal standard . Samples were stored overnight at -20°C and then centrifuged
(13,000 X g for 10 min) to precipitate proteins. The supernatant was aliquoted
and 100 1-11 was injected for HPLC analysis.
The AFB 1-GSH conjugate was separated using a Beckman System Gold
(Beckman, Fullerton, CA) chromatographic system, which consisted of a Model
126 pump, Model 166 uv-vis detector, Econosphere C,a (15 X 0.5) cartridge
column (AIItech Associates, Deerfield, IL), and System Gold data acquisition
software.

The flow rate was 1 ml/min and the column temperature was

maintained at 40°C. The separation protocol consisted of a binary reservoir
system using two mobile phases: reservoir A contained 0.1% H3PO. (pH 3.6 with
NH.OH) and reservoir B contained 95% CH30H and 5% tetrahydrofuran. Initial
concentrations were 90% A and 10% B, which was maintained for the first 2 min.
From 2 to 13 min, B increased to 38% at 13 min, and then to 60% at 16 min, and
90% at 17 min. From 17 min to 22 min, B decreased to 10%; the program was
terminated at 25 min. AFB, metabolites were detected at A.

= 345 nm.

Cytosolic

GST activity toward AFBO was determined with the same protocol used for
AFB 1-GSH determination with the exception that cytosolic GSH protein varied
between 50-1 000 1-1g
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lmmunodetection of GYP and GST

Microsomal proteins (100-200 11g protein) were separated by SDS-PAGE
and run at 100 mv (Laemmili, 1970). Proteins were transferred with a Semi-dry
Blotter (Buchler, Kansas City, MO) to nitrocellulose membranes, then were fixed
at 70°C for 30 min.

The membranes

were washed twice for 5 min in

TBS/Tween-20 (10 mM TRIS buffer, pH 7.4; 140 mM NaCI; 0.1% Tween-20).
The membrane was then incubated for 1 hr with 50 ml of high salt transfer buffer
(HST; 10 mM TRIS pH 7.4, 1 M NaCI , and 0.5% Tween-20) containing primary
antibody diluted according to the supplier's recommendation . After incubation,
the membranes were washed twice for 5 min with TBS/Tween-20, then once for 5
min in HST, followed by two 5-min washes in TBS/Tween-20. The membranes
were then incubated 1 hr with 50 ml of HST containing the secondary antibody
that was conjugated to horseradish peroxidase.

At the completion of this

incubation, the membrane was washed three times for 5 min each in TBS/Tween20, followed by a 10-min wash in HST. The membrane was then washed three
more times for 5 min each in TBS/Tween-20, and then 5 min in TBS. Proteins
were detected on X-ray film following a 1-min exposure to a chemiluminescence
solution.

GYP/A Activity

Determination of CYPIA activity was measured by a modification of 0dealkylation activities of ethoxyresorufin , and methoxyresorufin

methods as

described by Pohl and Fouts (1983) and Burke et a/., (1985),

respectively.
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Incubations contained 25 J..lg microsomal protein, 0.5 ml of 0.05 M Tris buffer (pH
7.5) , 5 J..lM substrate (in 2.5 J..ll of DMSO), 0.025 mM MgCI2, 1.6 mg/ml BSA, and
250 J..lM NADPH in a total volume of 0.5 J..ll. Reactions were run at 37°C and rates
were monitored with a spectrofluorometer (Fiuoro IV, Gilford, Oberlin, OH) at
excitation A.

=530 nm, and emission A. = 585 nm.

The reaction mixture without

NADPH ,H+ was equilibrated for 1 min at 37°C. After 1 min the reaction was
started by addition of NADPH.H•. The amount of increased fluorescence was
calibrated against a known concentration of resorufin.
CYP1A inhibitor (Correia, 1995)

Ellipticine, a specific

(50 J..!M final cone.), or furafylline, a specific

CYP1A2 inhibitor (Sesardic eta/., 1990; Kunze and Trager, 1993; Eaton and
Gallagher, 1994), (200 J..!M final cone.), was included in the reaction mix prior to
the addition of the NADPH ,H+ in some assays.

Glutathione S- Transferase Assays

Glutathione S-transferase activity was determined in cytoplasmic fractions
of lung and liver as described by Habig and Jakoby (1981) . The reaction mix
contained 900 J..ll KHP04 buffer (0.1M, pH 6.5), 60 J..ll of cytosol. and 20 J..ll CDNB
(50 mM in CH 3CH 20H). The reaction was initiated by the addition of 20 f..ll of 50
mM

reduced

glutathione

(GSH),

and

the

reaction

was

monitored

spectrophotometrically (Beckman DU 640, Beckman, Fullerton , CA) at A.

= 340

nm. The absorbance of a blank cuvette containing all components except the
cytosol was subtracted from that of the samples for the actual reaction rates.
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Statistical Analysis

Where appropriate, Student's t-test, linear regression analysis, and oneway analysis of variance were used to compare data (p < 0.05). Statistics were
analyzed with Sigma Stat statistical software (Jande! Scientific Software, San
Rafael , CA).

RESULTS

Microsomal AFB 1 Activation

Aflatoxin 8 1 kinetics for AFBO formation by hamster lung and liver
microsomes appeared to be nonlinear with ~ values of .89 and .91 for double
reciprocal plots for lung and liver, respectively, and .68 for an Eadie-Hofstee plot
in the liver.

These results indicate that microsomal activation did not follow

Michaelis-Menten kinetics, which precluded the ability to estimate an apparent Km
and

Vmax

(FIGS. 2-1 and 2-2).

Microsomes from 3-MC-treated animals were

significantly more active in activation of AFB, (p< 0.05) than those from the
controls (FIG. 2-3). In liver assays preincubated with ellipticine, a specific CYP1A
inhibitor, AFB 1-GSH formation in controls was reduced 44% at 20 llM and 48%
at 400 J.!M, and AFBO-GSH formation in the 3-MC treatment group was reduced
7% and 58%, respectively (FIG. 2-4). Pretreatment with furafylline, a specific
CYP1A2 inhibitor in humans, reduced AFB,-GSH production 4% at 25 llM and
40% at 400 llM in controls, and 9%, and 49%, respectively, in the 3-MC treatment
group (FIG . 2-4).
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CYPIA Activity

3-methylcholanthrene induced both ethoxyresorufin-0-dealkylase (EROD)
and methoxyresorufin-0-dealkylase (MROD) activity in microsomal preparations
from hamster liver and lung. EROD activity was increased 3.6-fold in the liver
and more than 40-fold in the lung . MROD activity was increased 5.6 times in the
liver and more than 15 times in the lung. In all cases except for 3-MC-induced
liver microsomes (which were reduced by 91 %) , 50 J.!M ellipticine inhibited 0dealkylase activity to nondetectable levels (TABLE 2-1).

Furafylline (200J.!M)

inhibited EROD activity in control lung microsomes by 37.1%, and by 31 .7% in
similarly treated 3-MC-induced microsomes. Pretreatment with furafylline failed to
inhibit MROD activity in either lung or liver control microsomes, but inhibited
MROD activity by 70.3% in 3-MC-induced lung microsomes and by 43.8% in 3MC induced liver microsomes (TABLE 2-1).

lmmunodetection of CYP1 A

CYP1A proteins were not detected in control lung microsomes but were
expressed in microsomes from 3-MC-treated hamsters. Low CYP1A levels were
found in control liver microsomes but the 3-MC group showed a 5.4-fold increase
in CYP1A protein (FIG. 2-5).

GST Yc proteins were found in both lung and liver

but no induction by 3MC was detected (FIG . 2-6).

Glutathione-$-Transferase Activity

40
As a broad measure of GST activity, chlorodinitrobenzene (CDNB)
conjugation was significantly induced in 3-MC-induced cytosol in both liver and
lung. Activity was highest in the liver (FIG. 2-7) and 3-MC-induced GST activity
increased by 36% in the liver and by 31 % in the lung (p < 0.05). BHA-induced
mouse liver cytosol had the highest activity for AFB, trapping and rat liver cytosol
had the lowest activity. Hamster cytosol at low protein levels had activity similar
to the rat, but at high protein concentrations, activity was close to the BHAinduced mouse cytosol (FIG. 2-8).

DISCUSSION

The objective of this study was to identify enzymes responsible for AFB 1
activation in the lung and liver of a normally resistant species, the Syrian golden
hamster.

To do this, we induced hamsters with 3-MC to overexpress certain

CYPs and GSTs in order to identify their roles in AFBO formation and
detoxification .
An attempt was made to measure apparent rate constants for AFB,
activation in lung and liver in the hamster.

A double-reciprocal plot of lung

showed clear departure from Michaelis-Menten kinetics and although a similar
plot for liver appeared to be linear, Eadie-Hofstee analysis confirmed it too was
nonlinear (FIG. 2-1). Biotransformation of AFB 1 is a complex multi-pathway
process and competing enzymes with different affinities for AFB 1 could shift
AFBO formation rates away from a linear pattern that would be seen using a
microsome-based assay system where multiple enzymes could be active
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simultaneously.

In a similar study of AFB, liver kinetics of microsomes from rat,

mouse, monkey, and human, nonlinear kinetics were observed in all cases except
for the formation of AFM 1 and AFP 1 in the mouse, where the KM for both of these
metabolites was approximately 30

~M

(Ramsdell and Eaton, 1990). A follow-up

study (Gallagher et a/. , 1996) utilizing a human cell line containing eDNA
expressed human CYP1A2 protein, AFBO formation followed Michaelis-Menten
kinetics but CYP3A4 eDNA microsomes had a nonlinear, sigmoidal relationship
between aflatoxin concentration and AFBO formation . The results of this study
indicate that although overall reaction rates with microsomal preparations are a
good indicator of AFBO activation , it is not a good system for measuring apparent
Km, and Vmax·

The CYP1A family has two members, CYP1A1 and CYP1A2. These two
proteins have about 70% homology and differ in their tissue localization with
CYP1A2 being primarily a hepatic enzyme, whereas CYP1A1 is found mostly in
extrahepatic tissues (Guengerich eta/. , 1995; Schweikl eta/., 1993; Shimada et
a/., 1989). Portions of the proteins are highly conserved. A monoclonal antibody
raised against rat CYP1A1 bound to CYP1A1 proteins from rat, mouse, rabbit,
hamster, and human, and it also bound to CYP1A2 proteins from rabbit and
humans but not to rat or mouse (Edwards et a/. , 1992).

The rat CYP1A1

monoclonal antibody that was used in this study recognized both CYP1A1 and
CYP1A2.

Western blots indicated that 3-MC had induced levels of CYP1A in

both the lung and liver (FIG . 2-2) . CYP1A protein was nondetectable in lung,
whereas the 3-MC treatment lanes showed clear induction but the specific
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isoform present was not discernible. Hepatic CYP1A was induced 5.4-fold in 3MC-induced hamsters and the bands appeared to be in alignment with the
CYP1A2 band of the standard lane. The amount of protein induction observed in
this study is similar to mRNA experiments (Sagami eta/., 1991), which showed
CYP1A1 was induced to the same level in lungs as in livers by 3-MC treatment,
whereas CYP1A2 mRNA was induced and expressed only in hamster liver.
CYP1A2 has been found to be active in metabolizing AFB, to the
detoxified AFM 1 in rat liver (Eaton and Gallagher, 1994) but producing the toxic
epoxide in human liver (Gallagher eta/, 1994; Ramsdell eta/., 1991).

Two 3-

MC- inducible GYPs have been reported from hamster liver (Fukuhara et a/.,
1994), one belonging to the CYP2A family, which is reported to produce AFBO,
and the other being CYP1A2, which is postulated to produce AFM, (Lai and
Chiang, 1990). Contrary to the hamster, in the rat, CYP2As are only slightly, if at
all , induced by 3-MC while CYP1A1 is strongly induced and CYP1A2 is
moderately induced (Correia, 1995).
In these experiments, although 3-MC caused an increase in CYP1A
expression and CYP1A associated 0-dealkylation activity, AFBO formation was
not significantly increased .

This indicates that CYP1A proteins are not involved

to a great extent in AFBO formation in the lung.
Conversely, in the liver there was a strong correlation between 3-MCinduced increases in AFBO formation by GYPs (4.8-fold), CYP1A2 protein
expression in Western Blots (5.5-fold), and methoxy-o-dealkylation activity (5.6fold) . Experiments using CYP1A inhibitors demonstrated a marked decrease in
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both AFBO formation by CYPs and CYP1A activity.

Although furafylline is a

potent inhibitor of CYP1A2 in human microsomes, ellipticine (which inhibits both
CYP1A proteins) was a stronger inhibitor of both AFBO formation and CYP1A
activity. The difference in furafylline potency between humans and the inhibitory
levels that were observed in the hamster may be due to differences in the
structure of CYP1A2 isoforms between the two species.

Thus, these

experiments suggest that CYP1A2 is involved in AFBO formation in hamster liver.
Based solely on the CYP mediated data, hamsters would be predicted to
be a very susceptible species. However, evidence from a long-term study with
hamsters given weekly intratracheal injections of AFB1 failed to show an increase
in either lung or liver tumors over controls and demonstrated that hamsters are
actually resistant to AFB 1 (Coulombe, unpublished).
Although hamster liver microsomes possess a 4-fold higher capacity than
rat liver microsomes to activate AFB1 , the relative resistance to the hamster has
been attributed to a more efficient GST-mediated AFB1 detoxification with GSH
(Lotlikar et a/., 1984).

Substantial differences exist between rodents in their

ability to conjugate the AFB 1-8,9-exCHJpoxide.

The AFB1-8,8-exo-epoxide is

efficiently trapped by mouse cytosolic GSTs, whereas rat cytosolic fractions are
relatively inefficient at conjugating the exo-epoxide (Raney et a/., 1992).

In

hamsters, a class GSTs show a 10-fold greater activity in conjugating AFBO
compared toll class GSTs (Goplan eta/., 1994).
Hamster GST proteins efficiently conjugate AFBO even at high AFB1
concentrations: Thus hamster liver is efficient in conjugating AFBO and provides
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a very powerful detoxification mechanism that would aid in the resistance of
hamsters to AFB 1. Our results place liver cytosol (i .e., GST activity) intermediate
between rat and BHA-induced mouse cytosol in its ability to conjugate AFBO. At
high protein concentrations, it was almost as efficient as the BHA-induced mouse
GST at trapping AFBO. However, consideration must be given to the possibility
t1at AFB1 concentration was insufficient to occupy all the sites in the mouse
GSTs; such substrate limitation would mask catalytic characteristics of the
enzyme.
These experiments demonstrated that 3-MC induced total GST activity in
both the lung and liver. CDNB assays detected a 36% increase in GST activity in
the liver and a 31% increase in the lung. Several chemical agents have been
found that induce the expression of GSTs (Langouet et at., 1996; Primiano et at.,
1992; Stresser et at. , 1994;) and the detoxification of AFB1 (Hayes et at. , 1994;
IVclellan et at., 1994).
It is not clear which isoforms of GST were induced in lung and liver by 3IVC treatment.

Resistance to the carcinogenic effects of AFB 1 in rodents has

been attributed to a class Yc isoforms of GST (Hayes et at., 1992; Mclellan et

a,, 1994). Primiano et at. (1992) reported that 3-MC induced a class GSTs in the
ret but Mclellan et at. (1994) found no indication that either Yc1 or Yc2 subunits
w~re

affected by 3MC treatment.

Although there was increased GST activity in

C)tosols from 3-MC-induced hamsters, Western blots showed that the Yc
sLbunits were not induced.
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As in human liver, results from these experiments indicate that CYP1A2
also appears to produce AFBO in the hamster liver.

In the hamster lung,

CYP1A1 but not CYP1A2 is expressed and is very active but does not play a role
in AFBO formation . This follows the pattern in other species where CYP1A2 is
primarily a hepatic enzyme and CYP1A1 is ex1rahepatic.

Glutathione S-

transferase Yc subunits are constitutively expressed in both lung and liver of
hamster and probably account for the species resistance to AFB, .
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TABLE 2-1
CYP1A Activation in Hamster Microsomes From Liver and Lung as
Measured by 0-0ealkylation Assays; Values Represent
the Means (± 1 SO) of 4 Animals.

EROO *

Control

nmol resorufin/min/mg protein
Lung
Liver

0.027 ± 0.012

0.081 ± 0.080

Control (+) Ellipticine

NO

NO

Control (+) Furafylline

0.017 ± 0.003

0.070 ± 0.010

3-MC

1.090 ± 0.120

0.291 ± 0.080

3-MC (+) Ellipticine

NO

NO

3-MC (+) Furafylline

0.744 ± .0150

0.200 ± 0.050

0.041 ± 0.010

0.232 ± 0.058

Control (+) Ellipticine

"NO

NO

Control (+) Furafylline

0.040 ± 0.010

0.230 ± 0.060

3-MC

0.437 ± 0.034

1.300 ± 0.151

3-MC (+) Ellipticine

NO

0.117 ± 0.014

3-MC (+) Furafylline

0.130 ± 0.040

0.730 ± 0.060

B. MROO *
Control

* Assay procedures are as described in "Materials and Methods." Ellipticine and
Furafylline final concentrations were 50 and 200 1-!M in DMSO. EROD =
ethoxyresorufin dealkylase, and MROD = Methoxyresorufin dealkylase.
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individuals ± 1 SD.* =significantly different from controls p < 0.05.
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CHAPTER 3
METABOLISM OF AFLATOXIN 8 1 IN THE RAT LUNG AND LIVER

ABSTRACT

Aflatoxin 8 1 (AFB 1) is a potent hepatocarcinogen and suspected etiological
agent in lung cancer as a result of inhalation of AFB,-contaminated grain dusts.
To better assess the risk posed by inhaled AFB, , rats were given daily
interperitoneal (i. p.) injections for 4 days of four different inducing agents which
have been shown to increase AFB, activation : phenobarbital (PB) a CYP2B1
inducer (40 mglkg) , monosodium glutamate (MSG, reported to induce CYP2C11 ,
25 mg/kg), 3-methylcholanthrene (3-MC, a CYP1A2 inducer, 25 mg/kg) , and
pregnenalone-16-a-carbonitirile (PCN, which induces CYP3A4, 50 mg/kg) . Six
hours following the last injection of inducing agent, 0.1mglkg (15 11Ci)
microcrystalline [3 H]AFB 1 was administered intratrcheally and 3 hr later, lungs and
livers were collected . In untreated animals, low levels of AFB,-DNA binding were
found in the lung (4 pmollmg DNA) compared to the liver (75 pmollmg DNA), and
[

3

H]AFB 1 was rapidly transported to the liver where the bulk of the activity was

localized. Pretreatment with PB increased eHJAFB,-DNA binding 4-fold in the
lung and by 3.7-fold in the liver. 3-methylcholanthrene, PCN , and MSG all failed
to increase [3 H]AFB 1-DNA binding over controls. The formation of AFB 1-exoepoxide (AFBO)-GSH in vitro with HPLC separation and ultraviolet (uv) detection
was not sensitive enough to reliably detect AFB, activation in the lung.

This

method worked well in the liver where results mirrored those of the AFB,-DNA
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binding studies with PB pretreatment increasing AFBO formation by 2.9-fold ,
whereas 3-MC, PCN , and MSG failed to increase AFBO formation over controls.
Microsomal CYP2B1 activity as measured by 0-deaklylation of pentoxyresorufin
was increased 53-fold in PB treated rats, and 200

1-~M

orphenadrine (a specific

CYP2B1 inhibitor) reduced 0-dealkylation 6.6-fold . No changes were noted with
CYP2B1 activity in the lung.

Pretreatment with PB increased CYP2B1

expression as determined by Western blots 2.6-fold in the lung while expression
in the liver was undetectable in controls but strong bands were detected in
microsomal protein from PB-treated rats.

CYP2B1 was found to be a primary

enzyme in AFB 1 activation in both the lung and the liver. There was no indication
that either 3-MC induction of CYP1A or PCN induction of

CYP3A enzymes

increased AFB 1 activation. Although both proteins were induced, neither protein
increased AFB 1-DNA binding or microsomal formation of ABO in either lung or
liver.

CYP2C11 was found in the lung but was not induced by MSG.

The

possible role of CYP2C11 could not be discounted since neither increased
expression of this enzyme nor AFB1 activation (as measured by AFB1-DNA
binding) was changed compared to controls.

Glutathione S-transferase Yc

enzymes were detected by Western blot in both the lung and the liver, but their
expression was variable. No indication was seen that either PB or 3-MC changed
levels of the Yc isoform.
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Introduction

Aflatoxin B1 (AFB 1) is produced as a secondary metabolite by the molds
Aspergillus flavus and parasiticus and is a common contaminant of food and feed
(Jelinek eta/., 1989). It is a potent animal hepatocarcinogen (Busby and Wogan,
1984; Vesselinovitch

et

a/.,

1972; Wogan

and

Newberne,

1967)

and

epidemiological evidence suggests that it is also a human carcinogen (Bosch and
Munoz, 1989; Groopman et a/., 1993; Groopman, 1994; Hall and Wild , 1994;
Linsell, and Peers, 1977 Shank, 1976). The carcinogenic potency of AFB1 in rats
is extremely high. A diet containing 15 ppb AFB1 , fed for 68-80 weeks, resulted
in a 100% incidence of hepatic tumors in rats (Wogan and Newberne, 1967) and
100 ppb for 54-88 weeks (Wogan et a/., 1974).

Based on the TDso values

developed by Gold eta/. (1984) , Eaton and Gallagher (1994) have calculated
that AFB1 is 1000 times more carcinogenic in the rat than is benzo(a)pyrene.
While the majority of research has centered on dietary exposure to AFB1 .
there is also evidence that respiratory exposure to AFB1-contaminated dusts in
agricultural and food processing activities may pose a lung cancer risk to workers
breathing these dusts ( Baxter et a/. , 1981 ; Burg et a/., 1981 ; Busby and Wogan,
1984; Sorenson eta/., 1981 ; Sorenson eta/. , 1984; Van Nieuwenhuize eta/.,
1973). Isolated case studies from peanut and grain processing facilities (Deger,
1976; Dvorockova, 1976), as well as epidemiological investigations (Hayes et al.,
1984; Van Nieuwenhuize et al., 1973), have found higher incidences of both
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pulmonary and liver tumors. relative to the general population, in workers
exposed to AFB1 -contaminated dusts.
Aflatoxin B1 is a procarcinogen and requires metabolic activation to the
reactive AFB1-8.9-epoxide (AFBO) to exert its carcinogenic effects (Eaton eta/.,
1994; Essigmann eta/., 1977; Swenson eta/., 1977). Aflatoxin B1 is primarily
metabolized by cytochrome P450s (CYPs), which are involved both in its
activation and detoxification (Eaton eta/., 1994). Species and tissue type vary in
the isoforms of CYPs that they express, and many CYPs are inducible by
exogenous agents, which in turn will modify the metabolism of AFB1 (Metcalfe et
a/. , 1981 ; Pelkonen eta/. , 1994; Takahashi eta/., 1995). Species susceptibility to
AFB1-induced carcinogenesis varies: Rats are susceptible, whereas mice and
hamsters are relatively resistant (Enomoto and Saito, 1972; Moore et al.. 1982;
Newberne and Butler. 1969). Differences in metabolic activity between species
or tissues determines susceptibility to AFB1 -induced carcinogenesis (Busby and
Wogan, 1984; Hsieh eta/.. 1977; Patterson. 1973; Salhab and Edwards, 1977).
The extent of covalent binding of AFBO to DNA is highly correlated to the
carcinogenic potency of AFB1 (Busby and Wogan , 1984; Garner, 1973:
7

Essigmann eta/., 1982). The critical initial lesion, the 8,9-dihydro-8-(N -guanyl)9-hydroxy-AFB1 , is formed in the reaction of DNA with AFBO (lyer eta/., 1994;
Lin eta/. , 1977). Detoxification of the epoxide occurs primarily by glutathione Stransferase (GST). The ability of species to trap AFBO by GST is proportional to
susceptibility to AFB1-induced carcinogenesis (Eaton and Gallagher. 1994;
Monroe and Eaton, 1987).
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Little is known about AFB1 metabolism in pulmonary tissue. Intratracheal
administration of AFB 1 failed to produce a significant incidence of tumors in
hamsters (Coulombe, unpublished).

3-methylcholanthrene (3-MC) induction

results in greater AFB1 activation in hamsters than that in other species such as
rat, rabbit, and mouse (Fukuhara eta/., (1990) . The aims of the experiments in
this chapter were to investigate AFB 1activation and detoxification in the lung and
liver of rat and to identify the P450 isoform (s) responsible for AFB 1 activation .
To do this, the effect of

phenobarbital (PB), 3-MC, pregnenalone-16-a-

carbonitirile (PCN) , and monosodium glutamate (MSG) pretreatment were
evaluated in regard to these parameters.

MATERIALS AND METHODS

Animals

Male 7-week-old Swiss-Webster mice, and male Sprague-Dawley

rats

(195-225 g) were purchased from Simonsen Laboratories (Gilroy, CA).

The

animals were housed in an AAALCAC accredited animal care facility and
maintained on certified chow and water ad libidum.

Chemicals and Reagents

Aflatoxin 8 1 (AFB 1) was purchased from Calbiochem (San Diego, CA) and
[

3

H]AFB 1 was obtained from Moravek Biochem., Inc. (Brea, CA). Aflatoxin G1

(AFG 1), 3-methylcholanthrene (3-MC), butylated hyxroxyanisole (BHA), butylated
hydroxytoluene,

1-chloro-2,4-di-nitrobenzene (CDNB), EDTA, phenylmethyl-

67
sulfonyl

fluoride

(PMSF),

ellipticine,

pentoxyresorufin ,

ethoxyresorfuin ,

pregnenalone-16-u-carbonitrile (PCN), phenobarbital (PB), reduced nicotinamide
adenine dinucleotide phosphate (NADPH ,+H \

reduced glutathione (GSH}, and

goat anti-mouse lgG secondary anti-body conjugated to horseradish peroxidase
(HRP) were purchased from Sigma Chemical (St. Louis, MO) . Resorufin was
purchased from Aldrich (Milwaukee, WI) , furafylline from Gentes! (Woburn, MA) ,
and halothane from Halocarbon Laboratories (River Edge, NJ). Authentic exoAFB1-8 ,9,-GSH (AFB1-GSH) was a gift from Dr. T. M. Harris, Vanderbilt
University (Nashville, TN). Dithiothreitol (OTT} , monosodium glutamate (MSG),
electrophoresis grade acrylamide, HPLC grade methanol, ammonium persulfate,
Scinteverse II scintillation cocktail, and tetrahydrofuran were obtained from
Fischer Scientific (Santa Clara, CA).

Anti-human CYP3A antisera was obtained

from Oxygene (Dallas, TX) , glutathione S-transferase

Yc rabbit antisera was

purchased from Biotrin (Dublin , Ireland), and anti-rat CYP1A1 goat antisera was
obtained from Daiichi Pure Chemicals (Tokyo, Japan). Goat anti-rabbit lgG and
rabbit anti-goat lgG secondary antibodies, both conjugated to horseradish
peroxidase (HRP), were purchased from Bio-Rad (Hercules, CA) .

Chemi-

luminescent detection of proteins was accomplished with an ECL Kit (Amersham,
Arlington Heights, IL) . Nitrocellulose membranes were purchased from Micron
Separations Inc. (Westborough, MA) .

Animal Treatment and Tissue Preparation
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Rats were given 100 J.!l i.p. injections of inducing agent, or control vehicle,
once daily for 4 days. The doses were as follows : PCN , 50 mg/kg in corn oil ; 3MC, 25 mg/Kg in corn oil; PB, 40 mg/Kg in DMSO; MSG, 25 mg/Kg in saline. Six
hours following the last dose, hamsters were anesthetized with halothane and
exsanguinated by severing the brachial arteries. Preparations of microsomes
and cytosolic fractions followed a modification of the method of Matsubara
(1974).

et a/. ,

Lungs and livers were removed , perfused with isotonic saline (0.9%

NaCI), and frozen in liquid N2. All tissues were stored at -80°C until use. Livers
and lungs were homogenized with a Polytron homogenizer (Brinkman Inc. ,
Westbury, NY) equipped with a 7-mm generator in ice cold

0.05 M KHP04

homogenizing buffer (pH 7.4) containing 1mM EDTA, 0.25 M sucrose, 0.15 M
KCI, 200 J.!M butylated hydroxytoluene (BHT), and 200 J.!M PMSF. The
homogenate was centrifuged at 600x g for 10 min followed by 10,000 x g for 10
min, and the supernatant was then centrifuged at 105,00 x g for 60 min. The
cytosolic fraction was collected and stored at -80°C. The microsomal pellet was
re-homogenized in wash buffer (pH 7.4) which contained 0.1 M Na4P207, 1 mM
EDTA, 20 J.!M BHT, and 200 J.!M PMSF, then centifuged again for 60 min at
105,000 x g. The microsomal pellet was then re-homogenized in 0.05 M KHP04
(pH 7.4) storage buffer containing 1 mM EDTA, 0.25 M sucrose, 2mM DTT, 200
J.!M PMSF, and 20% glycerol,

then stored at -80

oc

until use. Protein

concentrations were determined according to the Bradford (1976) method utilizing
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a BT2000 plate reader and Kinetic Calc® software suite (Fischer Scientific, Santa
Clara, CA) .

DNA Binding

Following 4 days of treatment with inducing agents, the rats were
anesthetized with halothane and then placed dorsally on an inclined board. The
head was restrained by hooking the upper incisors over a rubber band across the
board. The tongue was pulled out of the way with forceps to expose the trachea
and a single intratracheal dose (in 0.1-ml isotonic 0.9% saline suspension) of
eH]AFB1 (0.1mg/Kg; 15 ).ICi/animal) was administered with an illuminated
speculum (Oberg et a/., 1978). After 3 hr, the animals were euthanized with
halothane and exsanguinated by severing the brachial arteries. The lungs and
livers were removed , perfused with isotonic saline and then flash frozen in liquid
nitrogen and stored at -80°C.

DNA isolation and purification proceeded as

described by Coulombe eta/. (1984). Aliquots were analyzed for DNA content
(Burton, 1956) and specific activity was measured by liquid scintillation (model
3801 , Beckman, Irvine, CA).

Microsomal AFB1 Activation

Microsomal

biotransformation

of AFB1

was determined by

HPLC

quantification of the AFBO, as assessed by the formation of the AFB 1-GSH
conjugate. Determination of AFB1 oxidation was carried out in

250-~-tl

reactions

containing microsomal protein, 2 mM NADPH ,W , and 5 mM GSH , and 80 mM
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KHP04 buffer (pH 7.6), which included 25 mM sucrose, 25 mM KCI, and 5 mM
MgCI 2 .

BHA-induced mouse cytosol in excess (800

included to provide the glutathione S-transferase.
AFB 1 (in 5

~I)

~g

cytosolic protein) was

Varying concentrations of

were added to initiate the reaction. Aflatoxin 81 concentrations

were verified spectrophotometrically (A. = 360 nm;

E

= 21 ,800).

Reactions

proceeded for 10 min at 37°C, and then the reaction was stopped by the addition
of an equal volume of ice cold CH 30H containing AFG 1, which was included as
an internal standard.

Aflatoxin G1 ( 15-20

spectrophotometrically (A.= 362 nm;

E

~m)

concentrations were verified

= 17,700). Samples were stored overnight

at -20°C and then centrifuged in a table-top centrifuge at 13,000 X g for 10 min to
precipitate proteins. The supernatant was decanted into new tubes and 100

~I

was injected for HPLC analysis.
The AFB 1-GSH conjugate was separated using a Beckman System Gold
(Beckman, Fullerton, CA) chromatographic system which consisted of a model
126 pump, model166 ultraviolet-visual (UV-VIS) detector, econosphere C1s (15 X
0.5) cartridge column (AIItech Associates, Deerfield , IL), and System Gold data
acquisition software. The flow rate was 1 ml/min and the column temperature
was maintained at 40°C. The separation protocol consisted of a binary reservoir
system using two mobile phases: reservoir A contained 0.1% H3P04 (pH 3.6 with
NH40H) and reservoir B contained 95% CH30H and 5% tetrahydrofuran. Initial
concentrations were 90% A until 2 min, at which time B increased to 38% at 13
min, and then to 60% at 16 min, and 90% at 17 min. From 17 min to 22 min , B
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decreased to 10%; the program was terminated at 25 min . AFB1metabolites were
detected at A.

= 345 nm.

lmmunodetection of CYP and GST

Lung and liver microsomes or cytosol (100-200 1-1g protein) and standard
were loaded onto a 10% sodium dodecyl sulfate-polyacrylamide (SDS-PAGE) gel
and separated at 100 mv constant current by the method of Laemmili (1970) .
Proteins were transferred to nitrocellulose membranes with a Semi-dry Blotter
(Buchler, Kansas City, MO), then were fixed at 70°C for 30 min. The membranes
were blocked overnight with phosphate buffered saline (PBS) containing 0.5%
Tween 20 and 5% nonfat dry milk, then washed twice with PBS before incubation
for 1 hr with primary antibodies for either CYP1 A CYP2B 1, CYP2C 11 , CYP3A, or
GST Yc proteins. The membranes were then washed again four times and
incubated 1 hr with affinity-purified rabbit anti-goat, goat anti-rabbit, or human
anti-mouse lgGs conjugated to HRP followed by four washings in PBS. Proteins
were detected by chemiluminescence (ECL Kit, Amersham, Arlington Heights,
IL), and the film scanned with a Helwett Packard Scan Jet.

Relative band

intensities were measured with Sigma Scan image measurement software
(Jandel Scientific, San Rafael, CA) .

CYP2B1 Activity

Determination of CYP2B1 activity was measured by a modification of
activity of pentoxyresorufin 0-dealkylation method (PROD) as described by
Lubert eta/. (1985). Incubations contained 25 1-1g microsomal protein, 0.5 ml of
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0.05 M TRIS buffer (pH 7.5), 5

~M

MgCI 2 , 1.6 mg/ml BSA, and 250

substrate (in 2.5
~M

~I

of DMSO), 0.025 mM

NADPH in a total volume of 0.5

~~

Reactions were run at 37°C and rates were monitored with a spectrofluorometer
(Fiuoro IV, Gilford , Oberlin, OH) at an excitation 'A
585 nm .

= 530 nm , and

emission 'A

=

The reaction mixture without NADPH ,H+ was equilibrated for 1 min at

37°C. After 1 min the reaction was started by addition of

NADPH ,H+.

The

amount of increased fluorescence was calibrated against a known concentration
of resorufin. Orphenadrine (50

~M

final cone.) was included in the reaction mix

prior to the addition of the NADPH ,H+ in some assays.

Glutathione S- Transferase Assays

Glutathione S-transferase activity was determined in cytoplasmic fractions
of lung and liver as described by Habig and Jakoby (1981). The reaction mix
contained 900

~I

KHP04 buffer (0.1M, pH 6.5) , 60

~I

of cytosol , and 20

~I

(50 mM in CH3CH 2 0H) . The reaction was initiated by the addition of 20
mM

reduced

glutathione

(GSH),

and

the

reaction

was

CDNB

~I

of 50

monitored

spectrophotometrically (Beckman DU 640, Beckman, Fullerton, CA) at 'A

= 340

nm . The absorbance of a blank cuvette containing all components except the
cytosol was subtracted from that of the samples for the actual reaction rates.

Statistical Analysis

Where appropriate, Student's t-test, linear regression analysis, and oneway analysis of variance were used to compare data, and a 5% level was chosen
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for significance (p < 0.05). Statistics were analyzed with Sigma Stat statistical
software (Jandel Scientific Software, San Rafael, CA).

RESULTS

DNA Binding

Aflatoxin B1-DNA binding in control lung was approximately 4 pmol AFB1/
mg DNA, which was significantly less than that in the liver where AFB1-DNA
binding was approximately 70 pmoi/AFB1/mg DNA (FIGs

3-1 and 3-2) .

Phenobarbital pretreatment caused a 4.3-fold increase in AFB1 -DNA binding in
the lung (16.3 pmol AFB1/mg DNA) and a 3.8-fold increase in the liver (280 pmol
AFB 1/mg DNA).

3-methylcholanthrene, PCN, and MSG all failed to induce

increased AFB1-DNA binding in either lung or liver (FIGs. 3-1 and 3-2).

Microsomal AFB 1 Activation

Formation of AFBO by rat lung microsomes was at the lower limits of the
ultraviolet detector and did not provide reliable data for AFB1 activation. In the
liver, phenobarbital increased microsomal AFBO formation 3. 1-fold over controls,
but no significant differences were seen when similar comparisons were made
with the PCN , 3-MC, or MSG treatments groups (FIG. 3-3).

CYP281 Activity

CYP2B1 activity as measured by 0-dealkylation of pentoxyresorufin
(PROD) was very low in the lung, and differences of activity between microsomes
from control and PB induced rats were not significant (Table 3-1).

0-dealkylation
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in liver microsomes from PB treated animals were increased dramatically by more
than 5-fold over controls and pretreatment of 0-dealkylase assays with 50 J.!M
orphenadrine suppressed CYP2B1 activity by 85%.

lmmunodetection of CYPs and GST
Yc proteins

CYP2B1 was constitutively expressed in the lungs and overexpressed 2.6fold by phenobarbital pretreatment (FIG. 3-4A) . CYP2B1 was not detected in
control liver but was in the PB treatment group (FIG. 3-48) . CYP1A expression
was induced by 3-MC in lung from undetectable levels and by 3.7-fold in the liver
(FIG . 3-5) . CYP3A expression was induced by PCN 2.3-fold in the lung and 1.3fold in the liver (FIG. 3-6). Expression of CYP2C11 was unaffected by MSG in
both lung and liver but it was constitutively expressed at much higher levels in the
liver (FIG. 3-7). GST Yc was very variable in its expression, was found both in
the lung and the liver, and there did not appear to be a significant increase due to
either PB or 3-MC (FIG . 3-8).

Glutathione-$-Transferase Activity

Conjugation to glutathione s-transferase (as CDNB) showed no significant
increased activity by any of the inducing agents. Activity was 7.8-fold less in the
lung than it was in the liver (FIG. 3-9).
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DISCUSSION

The involvement of various GYPs and GSTs in AFB 1 activation and
detoxification was assessed by using four inducing agents: PB, 3-MC, PCN , and
MSG. Each agent was chosen for its proven ability to induce a CYP family that
has been shown to be involved in AFB1 activation, and in this way we hoped to
identify specific proteins involved in AFBO formation and detoxification.
Cytochrome P450 2B1 , CYP1A, CYP3A, and CYP2C11 were probed for
their involvement in AFB 1 activation by looking for increased AFB 1-DNA binding,
AFBO-GSH formation , and protein expression . Our results indicate that CYP2B1
is probably the most important rat enzyme in AFB1 activation. Phenobarbitaltreated rats showed a 2.6-fold increase in AFB1-DNA binding in the lung and a
3. 7-fold increase in the liver.

Unfortunately, AFB1-GSH levels were too low to

measure in the lung, but liver microsomes from PB-treated rats formed 3.2-fold
more AFBO than did microsomes from controls. Pretreatment of microsomes with
orphenadrine, a specific CYP2B1 inhibitor (Bachmann eta/., 1992; Hasegawa et
at. , 1994), reduced the amount of AFBO formed by 52% at 50 J.!mol and 75% at

5 mmol in the liver.
Cytochrome P450 2B1 activity, as measured by 0-dealkylation assays,
failed to show significant difference in activity from lung microsomes of PBtreated rats compared to controls, but CYP2B1 activity was increased 37-fold in
the liver and pretreatment with 50 J.!M orphenadrine quenched this increase by
85% . lmmunodetection of CYP2B1 showed clear induction in both lung and liver,
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which correlated well with DNA binding in both lung and liver and also AFBO
formation in the liver. The lack of increased CYP2B1 activity as measured by the
0-dealkylase assay could be due to sensitivity of the assay and the protein levels
that were used.
Rat liver CYP2B1 has been shown to activate AFB 1 to a mutagenic
species (lmaoka et at., 1992), and Metcalfe eta/. (1981) found increased AFB 1
activation in liver from

rats treated with

the CYP2B1

inducing agent,

phenobarbital (Chaney and Carlson , 1995; Paolini et at., 1995).

CYP2B1 is

found in both the lung , where it is a major isozyme (Dahl and Lewis, 1993), and
liver (Lacroix et at., 1993; Paolini et at. , 1996; Verschoyle et at., 1993).
Differences that were noted in AFB1 activation in the lung and liver could
be attributed to differences in the cellular morphology between the two organs.
Lung tissue is composed of some 40 different cell types with clara cells and to a
lesser extent type II cells responsible for most xenobiotic activation (Buchhagen,
1991 Plopper et at., 1987; Van Winkle eta/., 1996). In rat lung, CYP2B1 is ten
times more abundant in clara cells than it is in type II cells (Martin et at., 1993).
Species vary in their metabolic capacity to activate AFB1 in the lung, and the rat
has been shown to bind only 67% of the total AFB 1-DNA (Biswas et at., 1993) as
compared to the hamster, which correlates with much lower total CYP content in
rat than in either mouse or hamster (Piopper eta/. , 1987).
Clara cells make up only a fraction of all the cells in the lung , whereas the
hepatocytes, which contain the CYPs in the liver, make up the bulk of that organ.
It seems likely that although the rat lung is capable of activating AFB1 (as seen by
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AFB 1-DNA binding), the relatively small amount of activating proteins makes it
difficult to detect AFBO formation and most of the absorbed AFB 1 is transported
to the liver.
In this study, although microcrystalline AFB1 was administered intratracheally, the lung had much lower binding levels (15-fold in controls; 17.5-fold
in the PB group) than did the liver. This was also seen in vitro with AFB 1-GSH
formation where levels were below detection with our HPLC uv detection system.
It is clear that aflatoxin absorbed in the pulmonary tissues is rapidly transported to
the liver where the majority of metabolism takes place.
Toxic lipophilic substances such as benzo(a)pyrene and polychlorinated
bihphenyls (PCBs) that are absorbed from the intestine are shunted to the
lymphatic drainage and then to the peripheral vascular system . On the other
hand, AFB1 is taken by the blood directly to the liver, which may help contribute
to the specific hepatotoxicity of aflatoxins (Wilson eta/., 1985).

It may be that

this is also the case for absorption and transport from the lung, which could have
considerable significance considering the high AFB 1 levels that have been noted
in contaminated grain dusts.
Rat hepatic microsomes have been shown to be more mutagenic when
treated with AFB1 than are lung microsomes. and this has been attributed largely
to the abundance and activity of the CYP2C11 protein in the liver relative to the
lung (lmaoka eta/., 1992). In these studies, immunodetection showed that there
was 3.4-fold less CYP2C11 per J.!g microsomal protein in the lung than there was
in the liver.

CYP2C11 is a constitutive protein that is common in the liver of the
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adult male rat and is thought to be involved in AFBO formation (Eaton and
Gallagher, 1994). Contrary to the increased expression of CYP2C11 in adult
male rats that had been treated with MSG as pups (Pampori and Shapiro, 1994),
MSG administered to adults failed to induce increased expression of CYP2C11 .
Scanning densitometry of immunoblots specific for CYP1A protein showed
a sharp increase in expression from undetectable levels in the lung and a 3.8fold increase in the liver, but there was no concomitant increase in either AFBO
formation or DNA binding in either tissue. The CYP1A2 enzyme is highly
conserved among mammals (Pineau et a/, 1995) and has been reported in both
lung and liver of various species; (Foy eta/., 1996; Nerurkar eta/. , 1996), and is
inducible by several agents including 3-MC (Bani eta/., 1994; Chaloupka eta/.,
1994; Kim eta/., 1995; Correia, 1995). Kinetics from an in vitro model suggest
that CYP1A2 is the primary enzyme in the human liver for AFB1 activation
(Gallagher eta/., 1996), but it does not appear to play a role in AFB1 activation in
either rat lung or liver (Buetler eta/. , 1996; Shimada eta/., 1992).
The CYP1A antibody that was used recognizes both CYP1A1 and 1A2. 3methylcholanthrene strongly induces CYP1A1 in rat lung (Keith eta/., 1987), but
unlike the mouse, CYP1A2 is not inducible in rat lung by 3-MC (Dahl and Lewis,
1993).

The increase in CYP1A protein in the lung would be attributed to

CYP1A1 , a protein that to my knowledge has never been reported to activate
AFB1 .
In these studies, lung and liver microsomes prepared from rats treated with
PCN showed a 2.6-fold increase in CYP3A protein in the lung , and a 1.3-fold
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increase in the liver. In neither the lung nor the liver was there a significant
increase in AFBO formation as measured by AFB,-DNA binding or AFB, -GSH
conjugation .

CYP3A proteins are present in both lung and liver (Baron and

Voigt, 1990; Gallagher et a/., 1994; Kivisto et a/., 1995; Kivisto et a/., 1996) and
are inducible with several agents including PCN (Correia, 1995; Mani et a/. , 1993;
Quattrochi eta/., 1995).
lmmunoblots specific for GST Yc proteins detected GST Yc in both the
lung and the liver, but activity was very small in the lung relative to the activity in
the liver. Hayes eta/. (1991) reported the presence of an ethoxyquin-inducible
Yc2 GST that has high specific activity towards AFBO.

Phenobarbital has been

reported to induce several GST subunits (Derbel eta/., 1993}, but we found no
evidence in these studies that PB or 3-MC induced Yc subunits in either the lung
or the liver. GST activity as measured by the CDNB assay failed to detect any
increase in either the lung or the liver.
Several authors have suggested that the rat is an unsuitable model for
cancer risk in regard to AFB 1 intoxication. This assumption is based on the large
differences in the metabolism of AFB 1 that have been observed in the rat as
opposed to the human (Bruce, 1990; Gorelick, 1990; Gorelick et a/., 1994;
Hoseyni, 1993). This study further supports that supposition. While the human
liver metabolizes over 90% of the AFB,-epoxide produced in that tissue by
CYP1A2, and the remainder probably by CYP3A4, the rat does not appear to use
either one of these proteins. By contrast, results from these experiments have
shown that CYP2B1 is active in both lung and liver in metabolizing AFB, to the
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exo-epoxide in the rat, a protein that does not appear to play a similar role in
humans.
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TABLE 3-1
Cytochrome P450 (CYP) 281 Activation in Rat Microsomes from Lung and
Liver as Measured by Pentoxyresorufin 0-Dealkylase Activity

A Lung
Treatment

Orphenadrine

Reaction Rate
nmol min-1 mg-1 protein

±

DMSO

(-)

0.026

DMSO

(+)

0.023 ± 0.005

0.010

Phenobarbital

(-)

0.017 ± 0.005 *

Phenobarbital

(+)

0.022 ± 0.004 *

DMSO

(-)

0.023 ± 0.004

DMSO

(+}

0.032 ± 0.004

Phenobarbital

(-)

1.210 ± 0.297

Phenobarbital

(+)

0.184 ± 0.006

B. Liver

Values represent the means (± 1 SD) of three animals. Data are presented as
nmol resorufin produced per min per mg of microsomal protein.
procedures are as described in "Materials and Methods."
concentration was 200 f..LM
different p < 0.05.

in dimethylsulfoxide (DMSO).

Assay

Orphenadrine final
*

= significantly
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0.09% saline. Controls received saline only.

Lanes: 1 = 25 11g control liver

microsomal protein , 2-4 = 100 llg control lung microsomal protein, 5-7= 100 1!9
MSG-treated rat lung microsomal protein, 8-10 =control liver microsomal protein,
11-13 =control liver microsomal protein . Densitometer values are presented
below each blot, expressed in arbitrary units. Proteins were separated by PAGE
and visualized by chemiluminescence as outlined in "Materials and Methods."
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benzene (CDNB) assay. Values are means of animals(± 1SD). Procedures are
as described in "Materials and Methods."

Treatments are as follows :

PB =

Phenobarbital; 3-MC = 3-Methylcholanthrene; PCN = Pregnenalone-16-ucarbonitrile; MSG = Monosodium glutamate.

One-way ANOVA showed no

significant difference between the groups.

~=Control
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CHAPTER 4
INVESTIGATIONS OF ALTERNATE FORMS OF AFB 1 ACTIVATION

ABSTRACT

Cytochrome P450 (CYPs) enzymes are chiefly responsible for aflatoxin B1
AFB1 activation to the mutagenic and carcinogenic AFB1-exo-8,8-epoxide
(AFBO) . There is also evidence, especially in tissues such as kidney and lung,
that AFB1 can be activated to AFBO through cooxidation by prostaglandin Hsynthase (PHS) and lipoxygenases (LOX) during the metabolism of arachidonic
acid. These experiments tested the usefulness of using an AFBO-GSH trapping
assay coupled with HPLC detection to identify cooxidation of AFB 1 in rabbit lung
and liver. Both PHS and LOX activities were detected in both lung and liver with
approximately 3-fold higher activity in the lung.

Although measurable AFBO

formation was detected utilizing purified PHS, only minimal activation was
detectable in ram seminal vesicle microsomes, a rich source of PHS activity.
Furthermore, the use of indomethacin failed to reduce the amount of AFBO as
detected by HPLC. No AFBO formation could be attributed to 5-lipoxygenase
either as purified enzyme or as a cytosolic fraction from either lung or liver. The
general cytochrome P450 (CYP) inhibitor SKF-525A virtually shut down all AFBO
formation in both tissues, indicating that the AFBO formation was attributable to
CYPs. Although there was no indication of cooxidation from rabbit tissues in this
study, it could well have been a matter of detection sensitivity, with minor
amounts of undetected activation.
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INTRODUCTION

Aflatoxin B, (AFB,) is a mycotoxin contaminant of various foods and feed.
It is produced by the molds Aspergillus flavus and A. parasiticus (Denning, 1987).
It is a mutagenic (Coulombe et a/., 1982), and a potent hepatocarcinogen in
several species (Wogan , 1973). Epidemiological data indicate it is also a human
hepatocarcinogen (Groopman et a/., 1988).

Most research has focused on

dietary AFB, exposure; however, there is also concern in regard to human health
by occupational respiratory exposure to AFB,-contaminated grain dusts (Burg et
a/., 1981; Sorenson eta/, 1981 ; Sorenson eta/, 1984; Van Nieuwenhuize eta/,
1973). Although the liver is normally considered the target organ , AFB 1-induced
tumors in kidneys and lung have been reported from experimental animals (Busby
and Wogan , 1984; Dickens eta/, 1986;) and AFB 1 has been found in pulmonary
tissues from patients with lung cancer who had been exposed to AFB 1contaminated dusts by inhalation (Dvorockova eta/., 1981).
Aflatoxin B, is a procarcinogen that requires oxidative metabolism to the
AFB,-8,9-epoxide, which then binds to cellular macromolecules including the N7
position of guanine in cellular DNA (Bailey eta/, 1988; Misra eta/, 1983). Most
studies regarding AFB 1 activation have focused on cytochrome P450 (CYP), but
AFB, can also be activated through cooxidation by peroxyl radicals generated by
lipid hydroperoxides with the heme group of prostaglandin H synthase (PHS)
during the synthesis of prostaglandins from arachidonic acid (Eiing et a/, 1990;
Reed, 1988). Cooxidation of AFB 1 has been shown in mouse embryo fibroblasts
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(Amstad and Cerutti , 1983) and in ram seminal vesicle microsomes where the
7

major DNA adduct identified was 8,9-dihydro-2-(N -guanyl)-3-hydroxy-AFB 1 ,
(Battista and Marnell, 1985).
Cooxidation of AFB, has also been reported with lipoxygenases (Liu and
Massey, 1992), a group of nonheme iron dioxygenases that have high activity in
platelets (Lagarde eta/., 1985), polymorphonuclear leukocytes (Ochi eta/, 1983),
and the lung (Kusner et a/., 1989).

Purified soybean lipoxygenase has been

shown to be able to epoxidize benzo[a]-pyrene-7,8-dihydrodiol by an analogous
mechanism to PHS (Byczkowski and Kulkarni, 1989; Hughes eta/. 1989).
Lipoxygenase and PHS

systems may be an important metabolizing

system in pulmonary tissues where the CYP enzymes are not as abundant as
they are in the liver. In this investigation , we studied the PHS and lipoxygenase
activity of rabbit lung and examined the usefulness of the AFBO-GSH trapping
assay to detect its activity.

MATERIALS AND METHODS

Animals

Male New Zealand white rabbits (2.5-3.0 Kg) were purchased from R & R
Rabbitry (Stanwood, WA) and housed in an approved animal care facility.

Chemicals and Reagents

Aflatoxin B, (AFB,) was purchased from Calbiochem (San Diego, CA).
Aflatoxin G, , EDTA, phenylmethylsulfonyl fluoride (PMSF) , indomethacin, xylenol
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orange, arachidonic acid (20:ro6) , hematin, reduced nicotinamide adenine
dinucleotide phosphate (NADPH ,+H•), and reduced glutathione (GSH) were
purchased from Sigma Chemical Co. (St. Louis, MO.) Authentic exo-AFB 1-8,9GSH (AFB1-GSH) was a gift from Dr. T.M. Harris, Vanderbilt University (Nashville
TN).

Dithiothreitol (OTT), HPLC grade methanol, ammonium persulfate, and

tetrahydrofuran were obtained from Fischer Scientific (Santa Clara, CA) .
Prostaglandin H-synthase, recombinant human 5-lipoxygenase, ram seminal
vesicle microsomes, and nordihydroguaiaretic acid (NDGA) were obtained from
Oxford Biomedical Research, Inc. (Oxford, Michigan). Proadifen (SKF-525A) was
purchased from ICN Pharmaceuticals, Inc. (Aurora, OH).

Determination of Lipoxygenase Activity

Lipoxygenase activity was determined by the medthod of Waslidge and
Hayes (1995). Cytosol was diluted 1:1 with SOmM Tris-HCI buffer (ph 7.4). The
reaction was initiated by adding an equal volume of arachidonic acid (final
concentration 70 flM in 50 mM pH 7.4 Tris-HCL Buffer) and incubated at 37°C
for 10 min. The incubation was terminated with the addition of an equal volume
of FOX reagent (9:1 methanoi/H20 containing 25 mM H2S04, 100 J.!M xylenol
orange, and 100 J.!M FeS04 • 7H20). Oxidized xylenol orange concentration was
determined spectrophotometrically (Beckman DU 640, Beckman, Fullerton , CA)
at/..= 620 and e = 23,00 M- 1 cm·1.
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Determination Prostaglandin H-synthase
activity
Prostaglandin H-synthase activity was measured by 0 2 consumption in a
reaction containing

10~.d

of microsomal protein in 100 mM KHP0 4 buffer (pH7 .8)

containing 500 ).!M phenol (Egan et al, 1976; Hemler and Lands, 1980). After
preincubation for 1 min at 37°C, hematin was added to a final concentration of 1
).!M and the mixture was incubated for another 60 sec. The reaction was then
initiated by the addition of arachidonic acid to a final concentration of 100 J.!M. 0 2
levels were continually monitored with an oxygraph (Gilson, Worthington , OH) .

Determination of AFBt Activation
Microsomal

biotransformation

of AFB 1 was

determined

by

HPLC

quantification of the AFBO, as assessed by the formation of the AFB1-GSH
conjugate, which was carried out in 250-J.LI reactions containing 100-200 J.l9 of
microsomal protein, 2 mM NADPH ,H•, and

5 mM GSH, and

80 mM KHP04

buffer (pH 7.6) , which included 25 mM sucrose, 25 mM KCI, and 5 mM MgCI 2 .
Excess induced BHA mouse cytosol (800 J.l9 cytosolic protein) was included as a
source of GST. Arachidonic acid (200 J.LM) was included as substrate.
Indomethacin, a specific PHS inhibitor (Liu and Wells, 1995; Liu et al. , 1995),
DMSO, SKF-525A, a general CYP inhibitor (Lischke et al., 1995; Lock et al.,
1993; Maruyama, 1993) or buffer, were added and the reaction mix was
preincubated for 10 min , and then 20 J.LM (final cone.) AFB1 (in 5 J.LI) was added
to initiate the reaction. In all assays involving PHS, 1 ).!M hematin was included to
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insure saturation of the apoenzyme. For those reactions testing for lipoxygenase
activity, 600 f..lg

of rabbit cytosolic protein was included. Aflatoxin

concentrations were verified spectrophotometrically (A.

= 360

nm;

E

B1

= 21 ,800).

Reactions proceeded for 10 min at 37°C and were then stopped by the addition of
an equal volume of ice cold CH30H containing AFG1 (15-20f..lM) included as an
internal standard. Samples were stored overnight at -20°C and then centrifuged
at 13,000 X g for 10 min to precipitate proteins. The supernatant was decanted
into new tubes and 100 f..ll was injected for HPLC analysis.
The AFB1-GSH conjugate was separated using a Beckman System Gold
(Beckman, Fullerton, CA) chromatographic system, which consisted of a Model
126 pump, model 166 ultraviolet-visual (uv-vis) detector, econosphere C18 (15 X
0.5) cartridge column (AIItech Associates, Deerfield, IL), and System Gold data
acquisition software. The flow rate was 1 ml/min and the column temperature
was maintained at 40°C. The separation protocol consisted of a binary reservoir
system using two mobile phases: reservoir A (0.1% H3P04, pH 3.6 with NH.OH)
and reservoir B (95% CH 30H, 5% tetrahydrofuran). Initial concentrations were
90% A until 2 min, at which time B increased to 38% at 13 min , and then to 60%
at 16 min, and 90% at 17 min. From 17 min to 22 min, B decreased to 10%; the
program was terminated at 25 min. AFB1 metabolites were detected at A. = 345
nm.
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RESULTS

Prostaglandin H-synthase activity was detected in both lung and liver but
activity was 3-fold higher in the lung (FIG . 4-1). Similarly, lipoxygenase activity
was 3.5-fold greater in the lung than in the liver (FIG . 4-2) . AFBO formation was
detected with purified PHS enzyme but ram seminal vesicles produced barely
detectable levels (FIG . 4-3). Treatment of both lung and liver microsomes with
indomethacin, a specific PHS inhibitor, failed to alter AFBO formation (FIG. 4-3).
No AFB,-GSH conjugate was detected with purified 5-lipoxygenase enzyme and
NDGA failed to inhibit AFBO formation in assays where rabbit cytosolic fractions
were included in the mix (FIG. 4-3).
DISCUSSION

Cytochrome P450-mediated activation of AFB, is considered the primary
enzyme system responsible for epoxidation , but alternate pathways have also
been demonstrated. Prostaglandin H synthase (PHS)-dependent epoxidation of
AFB 1 can occur with CYP-mediated epoxidation (Battista and Marnett, 1985).
The contribution of PHS-mediated AFB 1 epoxidation varies between tissue type.
For example, PHS-dependent activation of AFB, accounts for less than 2% of the
contribution of CYPs to AFB 1 epoxidation in guinea-pig livers but as much as
50% in the kidney (Liu et a/. , 1990).

In these studies, pure PHS enzyme

appeared able to produce AFBO but no differences could be seen in AFBO
formation in either lung or liver when arachidonic acid was provided as a
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substrate and the PHS inhibitor indomethacin was preincubated with the reaction
mix. This is contrary to the 50% contribution of PHS seen in the guinea-pig
kidney. Since PHS activity was detected in both the lung and the liver, it would
seem logical to assume that it would be active in AFB1 activation , but perhaps it
was at very low levels and the AFBO trapping method was not sensitive enough
to detect differences.
Also examined was the role of lipoxygenase-mediated activation of AFB 1.
Lipoxygenase has also been shown to be active in both guinea-pig lung and liver
in activating AFB1 (Liu and Massey, 1992).

Lipoxygenase activity has been

reported at relatively high levels in human lung (Henke eta/., 1988; Kusner eta/.,
1989) and has been found to be capable of activating AFB1 in human placental
(Datta and Kulkarn i, 1994), and lung tissue (Donnely eta/., 1994). Using purified
5-lipoxygenase, we could detect no AFBO formation from the trapping studies,
and nordihydroguariaretic acid (NDGA), a specific inhibitor of lipoxygenase
activity (Haberstock et a/., 1996; Petit-Jacques and Hartzell , 1996; Lin et a/.,
1996), failed to reduce AFBO formation .

These data again suggest that 5-

lipoxygenase activation of AFB1 , if present, was too small to detect by the
methods used.

To further verify the role of metabolizing enzymes in rabbit lung

and liver, SKF-525A a general CYP inhibitor was included in some assays and
virtually eliminated AFBO formation .
Allthough cooxidation of AFB1 by PHS and lipoxygenase has been
reported from other species, we could not confirm that in the rabbit. However, it
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is very possible that these enzymes were activating AFB1 but at levels
undetectable with the method used in this study.
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TABLE 4-1
Aflatoxin 81-exo-8,9-epoxide (AFBO) Formation by Cooxidative Enzymes as
Measured by AFB 1-GSH Formation and Detected by HPLC.

A Microsomal Treatment

Lung

Liver

1
1
nmol AFB1-GSH min- mg· protein

±

Control

0.046

0.001

0.222 ± 0.039

Indomethacin

0.051 ± 0.022

0.022 ± 0.034

Nordihydroguaiaretic Acid

0.049 ± 0.019

0.224 ± 0.025

SKF-525A

B. Purified Enzyme
Prostaglandin H-synthase

ND

0.004

0.001

nmol AFB1-GSH min-1 mg 1 protein
0.217 ± 0.022

5 - Lipoxygenase
Ram Seminal Vesicles

±

ND
0.005

±

0.001

Assay conditions and HPLC protocol are as outlined in "Materials and Methods."
*=significantly different p< 0.05
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FIG. 4-1 . Comparison of prostaglandin H-synthase (PHS) activity in rabbit lung
and liver. Assay procedures are as outlined in "Methods and Materials." Values
are means from three individuals (± 1 SO) . * = Significantly different p < 0.05.
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CHAPTER 5
SUMMARY

This research has focused on the activation of aflatoxin 8 1 (AFB 1 ) in the
lung by the use of animal models in order to better understand the risk to people
from inhalation of AFB, -contaminated dusts. There is considerable variation not
only between species but also tissues in activation and sensitivity to the effects of
AFB, . We have examined some of the enzymes responsible for AFB 1 activation
in the lung from animals that are known to be susceptible to the carcinogenic
effects of this toxin (rat) and a resistant species (hamster) and contrasted this to
activation in the liver.

Aflatoxin B, can be metabolized to various products

including the exo-epoxide, which will be specifically referred to as activation .
Results from these studies showed that in both rat and the hamster, lung
tissue could activate AFB, and thus present this tissue with a potential
carcinogenic challenge. It was also found that although AFB 1 was administered
intratracheally and was absorbed first by the lung , the majority of the AFB 1 was
not activated there, but rather transported to the liver, where, by far, most of the
activation occurred. This highlights ·the serious nature of the potential exposure
of workers to high levels of AFB,-contaminated dusts. Not only does the lung
possess the enzymatic machinery to activate AFB, itself, but it also is a very
efficient absorptive organ from which AFB, is transported to the liver where there
is a rich supply of activating proteins.
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The large variation in species susceptibility to AFB 1 has made animal
studies difficult to interpret in regard to human responses to AFB 1. Differences in
both cytochrome P450s and glutathione S-transferases and their capacity to
metabolize AFB1 vary greatly between species. A better understanding of which
isozymes are involved in activation will help in the understanding of species and
tissue susceptibility. These experiments illustrated clear differences between the
rat and the hamster as to the specific proteins involved in AFB 1 metabolism. We
found that CYP1A2 appears to be involved in activation in the hamster liver but
that it does not play a role in the hamster lung. Although CYP1A1 activity is
greatly increased in the lung, CYP12 activity is not. To my knowledge CYP1A1
has never been shown to be involved in AFB1 metabolism and certainly did not
appear to be involved in its activation in hamster lung.
Western blots in combination with 0-dealkylation assays indicate that
CYP1A1 was induced in the lung but not CYP1A2 , whereas in the liver CYP1A2
was strongly induced. This follows a pattern similar to the rat where CYP1A1 is
inducible in the lung but CYP1A2 is not. It is interesting to note that CYP1A2 has
been reported responsible for greater than 90% of all AFB 1 activation in human
liver at dietary exposure levels.
Unlike the hamster, the rat CYP1A2 did not appear to be involved in AFB1
activation. In the lung, the only protein that appeared to respond to induction and
increase AFB1-DNA binding was CYP2B1 . We found it constitutively expressed
in the lung and phenobarbital induced higher levels in this tissue. Our results
indicate that CYP2B1 is a primary protein in AFB 1 activation in the lung.

A
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different pattern was found in the liver where CYP2B1 was not detected in
controls but was strongly induced by phenobarbital , which resulted in large
increases in AFB, activation. Low-level activation of AFB 1 in the liver may have
been by CYP2C 11 , a protein known to have high specific activity towards AFB 1
and which we found constitutively expressed in the liver.
Species resistance

to AFB,

is largely attributed to the detoxifying

glutathione S-transferases, which, like the cytochrome P450s that vary greatly in
their ability to activate AFB, , also vary greatly as to their capacity to conjugate
with the exo-epoxide. Glutathione S-transferase detoxification of the AFB 1-exoepoxide appears to be a much more important feature of resistance than does
that of the cytochrome P450 complement. Hamster had a much higher capacity
to activate AFB 1 in the lung and equal that of the liver in rat. The hamster is
known to be a resistant species, whereas the rat is susceptible. This could have
important ramifications in humans where, unlike rodents , which have Yc class
GSTs that contain isoforms with high specific activity towards AFB 1 ,

the

predominant GSTs are Mu class, which have low affinity for AFB 1 . The likelihood
that the activated exo-epoxide would bind to DNA rather than conjugating to
glutathione and then be eliminated, would be higher in humans than in the rodent
models.
Cooxidation of AFB, has been suggested as an alternate activating
pathway in extrahepatic tissues. Our studies found that if this was occurring in
rabbit lung, the amounts were too small to be detected by the HPLC method that
we used.

Previous work in another laboratory has shown that cooxidation
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contributes from anywhere between 2% (liver) to as much as 50% (kidney) of the
AFB, activation in the guinea-pig. We saw no indication that the rabbit lung
contributed anything near 50% of the activation.
This was also a problem with P450 activation where AFBO formation was
small. In the rat lung, virtually no AFBO formation was detected, but radiolabeling
studies showed that AFB,-DNA binding was occurring.

The HPLC detection

method worked with hamster lung, but here activation was much higher than with
the rat. This illustrates the constraints of this method , which is very useful when
AFBO formation is at higher levels, but becomes unreliable when detection is
required of small amounts of AFBO formation .
An attempt was made in these studies to obtain kinetic data in regard to
activation of AFB, in the hamster.

It was found that by using microsomes

containing several isoforms of P450s, all of which could be metabolizing AFB 1 at
different rates and at different concentrations, linear kinetics was unatainable.
For this kind of study, a system expressing only one isoform is required to get
accurate kinetic data.
Further work needs to be done to identify the proteins involved in AFB 1
activation of the lung of hamster in order to judge its usefulness as a model for
human exposure. In addition, identification and relative abundance of the specific
GSTs responsible for AFB 1 activation in the lung of hamster and rat would clarify
the question of interspecies susceptibility.
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Regardless of tissue susceptibility, absorption by the lung is an efficient
organ in the uptake and absorption of AFB1-contaminated dusts. There is little
information available concerning the transport of AFB1 in the blood stream. Since
the liver appears to show the highest amount of activity following intratracheal
injections of AFB1 , a study concern ing the mechanisms of lung absorption and
the AFB1 carrier proteins in the plasma would be a logical next step in regard to
the AFB1 toxicology of pulmonary exposure to contaminated grain dusts.
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